<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">101702</article-id><article-id pub-id-type="doi">10.7554/eLife.101702</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>TPR is required for cytoplasmic chromatin fragment formation during senescence</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bartlett</surname><given-names>Bethany M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1999-7675</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Yatendra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Boyle</surname><given-names>Shelagh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chowdhury</surname><given-names>Tamoghna</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-6287-7227</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Quintanilla</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Boumendil</surname><given-names>Charlene</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1953-3902</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7989-7329</contrib-id><email>juan.acosta@unican.es</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6660-7735</contrib-id><email>wendy.bickmore@ed.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01nrxwf90</institution-id><institution>MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh</institution></institution-wrap><addr-line><named-content content-type="city">Edinburgh</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01nrxwf90</institution-id><institution>Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh</institution></institution-wrap><addr-line><named-content content-type="city">Edinburgh</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d963745</institution-id><institution>Institute of Biomedicine and Biotechnology of Cantabria (CSIC-Universidad de Cantabria)</institution></institution-wrap><addr-line><named-content content-type="city">Santander</named-content></addr-line><country>Spain</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051escj72</institution-id><institution>Institute of Human Genetics, UMR9002, CNRS – Université de Montpellier</institution></institution-wrap><addr-line><named-content content-type="city">Montpellier</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e101702</elocation-id><history><date date-type="received" iso-8601-date="2024-07-24"><day>24</day><month>07</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-11-25"><day>25</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2024-04-18"><day>18</day><month>04</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.04.18.590085"/></event></pub-history><permissions><copyright-statement>© 2024, Bartlett et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Bartlett et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-101702-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-101702-figures-v3.pdf"/><abstract><p>During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>genome integrity</kwd><kwd>senescence</kwd><kwd>nuclear periphery</kwd><kwd>oncogene</kwd><kwd>heterochromatin</kwd><kwd>inflammation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00007/2</award-id><principal-award-recipient><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00035/7</award-id><principal-award-recipient><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/217120</award-id><principal-award-recipient><name><surname>Kumar</surname><given-names>Yatendra</given-names></name><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C47559/A16243</award-id><principal-award-recipient><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Ministry of Science and Innovation, Government of Spain</institution></institution-wrap></funding-source><award-id>Proyecto PID2020-117860GB-I00</award-id><principal-award-recipient><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-CE12-0039</award-id><principal-award-recipient><name><surname>Boumendil</surname><given-names>Charlene</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Evidence is provided suggesting that heterochromatin re-organisation during cell senescence can compromise the structural integrity of the nucleus, leading to activation of an inflammatory process.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>DNA damage, such as short telomeres (replicative senescence) or oncogene signalling, can trigger senescence, an irreversible cell cycle arrest programme. During oncogene-induced senescence (OIS) chromatin organisation is dramatically disrupted. Pre-existing heterochromatin moves away from the nuclear periphery (<xref ref-type="bibr" rid="bib8">Chandra et al., 2012</xref>), forming internal senescence-associated heterochromatic foci (SAHF) (<xref ref-type="bibr" rid="bib45">Narita et al., 2003</xref>).</p><p>Senescent cells also activate a gene expression programme that leads to the secretion of a cocktail of inflammatory cytokines, chemokines, and growth factors – known as the senescence-associated secretory phenotype (SASP) (<xref ref-type="bibr" rid="bib10">Coppé et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Acosta et al., 2013</xref>). The SASP can contribute to tumour suppression by enhancing immune cell recruitment (<xref ref-type="bibr" rid="bib30">Kale et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Xue et al., 2007</xref>), but it can also promote tumour growth (<xref ref-type="bibr" rid="bib33">Kuilman et al., 2008</xref>) and immunosuppression (<xref ref-type="bibr" rid="bib55">Ruhland et al., 2016</xref>). Activation of SASP-related genes is primarily driven by the transcription factors (TFs) NF-κB (subunit p65) and C/EBPβ (<xref ref-type="bibr" rid="bib9">Chien et al., 2011</xref>; <xref ref-type="bibr" rid="bib33">Kuilman et al., 2008</xref>) and is accompanied by substantial changes in the landscape of active enhancers (<xref ref-type="bibr" rid="bib42">Martínez-Zamudio et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Tasdemir et al., 2016</xref>).</p><p>As well as relocating to the nuclear interior to form SAHF, heterochromatin blebs off from the nuclear membrane during OIS, forming cytoplasmic chromatin fragments (CCFs) (<xref ref-type="bibr" rid="bib28">Ivanov et al., 2013</xref>). The relationship between SAHF, the SASP, and CCFs has been elusive. CCFs are enriched for the heterochromatin-associated histone modifications H3K9me3 and H3K27me3 (<xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Ivanov et al., 2013</xref>). CCFs are also positive for γ-H2AX, suggesting that DNA damage plays a role in CCF formation (<xref ref-type="bibr" rid="bib28">Ivanov et al., 2013</xref>). In the cytoplasm, CCFs are sensed by the cGAS-STING pathway, which leads to activation of the SASP via NF-κB signalling (<xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Glück et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Yang et al., 2017</xref>).</p><p>We have previously shown that the nuclear pore basket protein TPR, that excludes heterochromatin from the vicinity of nuclear pores (<xref ref-type="bibr" rid="bib32">Krull et al., 2010</xref>), is necessary for both the formation and maintenance of SAHF, as well as for activation of the SASP, during OIS (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). The AT-hook chromatin protein HMGA1 has similarly been shown to be a component of SAHFs and to be required for SAHF formation (<xref ref-type="bibr" rid="bib46">Narita et al., 2006</xref>). Here, we investigate the requirement of TPR for SASP activation during OIS as well as during the early replicative stress that occurs in response to oncogenic RAS induction. Our results suggest a key role for TPR in the activation of innate immune signalling linked to formation of CCFs. We also show that HMGA1 is required for CCF formation. These data suggest that heterochromatin re-organisation away from the nuclear periphery underlies a loss of nuclear integrity manifesting as CCF formation, and that this can lead to activation of innate immune signalling during senescence.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Putative enhancers dependent on TPR during senescence are enriched for binding sites of inflammatory TFs</title><p>TPR is a 267 kDa protein (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) added to the nuclear pore late in telophase after other nuclear pore components and is anchored to the nuclear pore basket through its interaction with NUP153 (<xref ref-type="bibr" rid="bib22">Hase and Cordes, 2003</xref>). Knockdown or degradation of TPR has been shown not to affect NUP153 recruitment to the nuclear pore (<xref ref-type="bibr" rid="bib22">Hase and Cordes, 2003</xref>; <xref ref-type="bibr" rid="bib4">Aksenova et al., 2020</xref>). TPR is necessary for both the formation and maintenance of SAHF, as well as for activation of the SASP, during OIS (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). To further study the role of TPR in the activation of the SASP during OIS, we used IMR90 fibroblasts harbouring an estrogen-inducible (4-hydroxytamoxifen [4-OHT]) oncogenic RAS<sup>G12V</sup> mutation (ER:HRAS<sup>G12V</sup>) (<xref ref-type="bibr" rid="bib3">Acosta et al., 2013</xref>). The chromatin regulatory landscape of IMR90 cells changes during OIS (<xref ref-type="bibr" rid="bib63">Tasdemir et al., 2016</xref>) and there is evidence that some nucleoporins interact with enhancers and regulate the transcriptional activity of associated genes (<xref ref-type="bibr" rid="bib27">Ibarra et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Pascual-Garcia et al., 2017</xref>). Therefore, we investigated whether TPR influences putative enhancers that control SASP gene activation. We used ATAC-seq to identify whether there are regions of accessible chromatin that are specific to senescent cells, and that are TPR-dependent – i.e., are lost after TPR depletion by siRNAs at day 8 (d8) of RAS-induced senescence (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Senescence-specific accessible chromatin sites dependent on TPR are near senescence-associated secretory phenotype (SASP) genes and are enriched in binding sites for SASP-related transcription factors.</title><p>(<bold>A</bold>) Model of the nuclear pore showing the location of TPR in the nuclear basket and heterochromatin exclusion at the pore. (<bold>B</bold>) Schematic of experimental protocol for senescence induction in IMR90 cells. After 8 days of treatment with 4-hydroxytamoxifen (4-OHT), the control (STOP) line continues to proliferate while the RAS line becomes senescent due to induction of RAS<sup>G12V</sup> expression. (<bold>C</bold>) Heatmap showing ATAC-seq signal in control (STOP) and OIS (RAS) cells 8 days after treatment with 4-OHT and transfection with either control (CTRL) or TPR siRNAs. SEN<sup>+</sup> indicates signal specific to senescent cells and TPR<sup>+</sup> indicates dependence on TPR. Intensity scale represents reads per kilobase per million mapped reads (RPKM). (<bold>D</bold>) Track views of ATAC-seq data from STOP and RAS cells treated with CTRL or TPR siRNAs at <italic>IL1B</italic> (top) and <italic>IL8</italic> (bottom) gene loci. (<bold>E</bold>) HOMER motif analysis of the senescence and TPR-dependent ATAC-seq peaks (SEN<sup>+</sup> TPR<sup>+</sup>) and the peaks that are dependent on senescence but not TPR (SEN<sup>+</sup> TPR<sup>-</sup>). The top 10 motifs are shown for each category of peaks. For both analyses all motifs have a p-value&lt;10<sup>–13</sup>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>TPR-dependent senescence-specific accessible chromatin peaks are enriched in H3K27ac and associated with genes relevant to inflammation.</title><p>Related to <xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>A</bold>) Volcano plot of differential accessibility analysis of day 8 (d8) ATAC-seq peaks in RAS siCTRL vs STOP siCTRL. The horizontal dashed line indicates an adjusted p-value (FDR) of 0.05. Peaks with a significant increase in accessibility in senescent cells (SEN<sup>+</sup>) are coloured blue if their accessibility decreases on siTPR treatment (SEN<sup>+</sup> TPR<sup>+</sup>), or pink if their accessibility does not change on siTPR treatment (SEN<sup>+</sup> TPR<sup>-</sup>). (<bold>B</bold>) Heatmap of H3K27 acetylation (H3K27ac) ChIP-seq data from growing and senescent IMR90 cells (<xref ref-type="bibr" rid="bib50">Parry et al., 2018</xref>) for the TPR-dependent (TPR<sup>+</sup>) and TPR-independent (TPR<sup>-</sup>) peaks defined in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. (<bold>C</bold>) Top ranking results of gene ontology analysis of genes close to SEN<sup>+</sup>TPR<sup>+</sup> peaks using the Genomic Regions Enrichment of Annotations Tool (GREAT) package (<xref ref-type="bibr" rid="bib43">McLean et al., 2010</xref>). (<bold>D</bold>) As in (<bold>C</bold>) but for genes close to SEN<sup>+</sup> TPR<sup>-</sup> peaks.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig1-figsupp1-v3.tif"/></fig></fig-group><p>Of the 6826 peaks with a significant increase in accessibility in senescent (RAS siCTRL) compared to non-senescent control (STOP siCTRL) cells (senescent-dependent (SEN<sup>+</sup>)), 1187 are also TPR-dependent (SEN<sup>+</sup>TPR<sup>+</sup>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Many of these are close to key SASP genes, such as <italic>IL1B</italic> and <italic>IL8</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Both SEN<sup>+</sup>TPR<sup>+</sup> and SEN<sup>+</sup>TPR<sup>-</sup> peak categories showed an increase in H3K27 acetylation (H3K27ac), as assayed from ChIP-seq data (<xref ref-type="bibr" rid="bib50">Parry et al., 2018</xref>), in senescent IMR90 ER:HRAS<sup>G12V</sup> cells when compared with the non-senescent control (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). This suggests that the regions which become accessible upon senescence may function as senescence-specific enhancers, regardless of their dependence on TPR.</p><p>Gene ontology (GO) analysis carried out using the Genomic Regions Enrichment of Annotations Tool (GREAT) (<xref ref-type="bibr" rid="bib43">McLean et al., 2010</xref>) showed that TPR-dependent peaks are significantly near to known SASP factor genes, and to genes enriched in Biological Process and Molecular Function categories such as ‘positive regulation of inflammatory response’, and genes involved in cytokine activity and cytokine receptor binding (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). TPR-independent senescent-dependent peaks showed proximity to chemokine receptor genes (<italic>XCR1</italic>, <italic>CCR1</italic>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>) whose expression allows cells to sense and respond to chemokines such as those secreted in the SASP (<xref ref-type="bibr" rid="bib10">Coppé et al., 2010</xref>). However, the TPR-independent peaks did not show proximity to any SASP factor genes, suggesting that senescence-activated regulatory elements close to SASP genes (<xref ref-type="bibr" rid="bib63">Tasdemir et al., 2016</xref>) may all be TPR-dependent.</p><p>HOMER motif analysis (<xref ref-type="bibr" rid="bib25">Heinz et al., 2010</xref>) revealed that d8 SEN<sup>+</sup>TPR<sup>+</sup>, but not TPR-independent (SEN<sup>+</sup>TPR<sup>-</sup>), ATAC-seq peaks are enriched for binding motifs of TFs, such as NF-κB and C/EBPβ, known to regulate the SASP (<xref ref-type="bibr" rid="bib2">Acosta et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Kuilman et al., 2008</xref>; <xref ref-type="fig" rid="fig1">Figure 1E</xref>). This indicates that TPR is involved in regulation of the NF-κB-dependent pro-inflammatory SASP during OIS. Both categories of senescent-dependent peaks are enriched in binding motifs for components of the AP-1 complex (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), a pioneer TF premarking prospective senescence enhancers (<xref ref-type="bibr" rid="bib42">Martínez-Zamudio et al., 2020</xref>). This suggests that the initial shaping of the senescence regulatory landscape by AP-1 is unaffected by TPR knockdown.</p></sec><sec id="s2-2"><title>Prolonged loss of TPR during senescence blocks NF-κB activation</title><p>Because of the enrichment for NF-κB motifs in the d8 senescence- and TPR-dependent (SEN<sup>+</sup>TPR<sup>+</sup>) putative enhancers, we set out to investigate whether NF-κB activation is affected by TPR knockdown in senescent cells.</p><p>Inactive NF-κB dimers are held in the cytoplasm through their association with IκB proteins. Inducing stimuli trigger activation of the IκB kinase complex (IKK), which leads to phosphorylation and degradation of IκB, allowing the translocation of NF-κB to the nucleus, where it promotes the transcription of target genes (<xref ref-type="bibr" rid="bib24">Hayden and Ghosh, 2012</xref>). We used immunofluorescence to assess NF-κB localisation in the nucleus and in the cytoplasm immediately around the nucleus (see Methods) during OIS and in the presence or absence (siRNA knockdown) of TPR (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As expected, NF-κB remained cytoplasmic in control (STOP) cells, but translocation to the nucleus could be detected in senescent RAS cells, with SAHF readily apparent from DAPI staining in the nucleus of these cells. As we previously reported, knockdown of TPR (siTPR) in RAS cells blocks SAHF formation, but it also results in reduced nuclear localisation (decreased nucleocytoplasmic ratio) of NF-κB, consistent with decreased NF-κB activation (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Prolonged loss of TPR during senescence blocks NF-κB activation.</title><p>(<bold>A</bold>) TPR and NF-κB immunostaining in control (STOP) and oncogene-induced senescence (OIS) (RAS) cells after 4-hydroxytamoxifen (4-OHT) and siRNA (control and TPR) treatment for 8 days. Scale bar: 10 μm. (<bold>B</bold>) Quantification of NF-κB nucleocytoplasmic ratios in experiment described in (<bold>A</bold>). Kruskal-Wallis testing was used to determine statistical significance followed by Dunn’s post hoc testing. n.s. p&gt;0.05, ***&lt;0.001. (n) indicates the number of cells analysed for each sample. Data from a biological replicate are in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>. Statistical data are in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>. (<bold>C</bold>) Immunoblots of extracts from control (STOP) and OIS (RAS) cells after 4-OHT and siRNA treatment for 8 days for phosphorylated (pS536) and total NF-κB with vinculin as a loading control. Numbers below indicate the ratio of band intensity for NF-κBpS536 or NF-κB and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. (<bold>D</bold>) As in (<bold>C</bold>) but for phosphorylated (pS176/180) IKKα/β and total IKKα and with β-actin as a loading control. Data from biological replicates of (<bold>C</bold>) and (<bold>D</bold>) are in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>. (<bold>E</bold>) Above: Schematic of controlled media experiment to investigate whether TPR loss causes a general defect in NF-κB transport. STOP and RAS cells were grown for 8 days and treated with 4-OHT and siRNAs. On day 8 (d8) they were treated for 45 min with conditioned media (CM) taken from either STOP or RAS cells grown in 4-OHT-containing media for 8 days. Below left: NF-κB immunostaining in STOP or RAS cells treated with CM harvested from STOP (left) or RAS (right) cells. Scale bar: 50 μm. Below right: Same experiment with images shown at greater magnification. Scale bar: 10 μm. (<bold>F</bold>) Quantification of NF-κB nucleocytoplasmic ratios for experiment shown in (<bold>E</bold>). Data from a biological replicate are in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>. Statistical data are in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantification of NF-κB nucleocytoplasmic ratios and statistical analysis for data in <xref ref-type="fig" rid="fig2">Figure 2B and F</xref>, and for biological replicates in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and D</xref>.</title><p>Median NF-κB nucleocytoplasmic ratios (n/c) and number of cells analysed for day 8 (d8) STOP or RAS cells subject to knockdown with control (CTRL) or TPR siRNAs, and for experiments where these cells were treated with conditioned media (CM) from either STOP or RAS cells. Kruskal-Wallis testing was used to determine statistical significance for each replicate (p-value in parentheses) followed by Dunn’s post hoc testing. p-values after Benjamini and Hochberg correction.</p></caption><media mimetype="application" mime-subtype="docx" xlink:href="elife-101702-fig2-data1-v3.docx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-101702-fig2-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig2-data3-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>TPR depletion blocks NF-κB activation during senescence.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>A</bold>) Quantification of NF-κB nucleocytoplasmic ratios by immunofluorescence in STOP and RAS cells after 4-hydroxytamoxifen (4-OHT) and siRNA treatment for 8 days. Kruskal-Wallis testing was used to determine statistical significance followed by Dunn’s post hoc testing. n.s. p&gt;0.05, ***&lt;0.001. (n) indicates the number of cells analysed for each sample. Data are from a biological replicate of the experiment shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. Statistical data are in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>. (<bold>B</bold>) Immunoblots in extracts from control (STOP) and OIS (RAS) cells after 4-OHT and siRNA (control and TPR) treatment for 8 days for phosphorylated (pS536) and total NF-κB with vinculin as a loading control. Numbers below indicate the ratio of band intensity for NF-κBpS536 or NF-κB and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. Biological replicate of data in <xref ref-type="fig" rid="fig2">Figure 2C</xref>. (<bold>C</bold>) As in (<bold>B</bold>) but for phosphorylated (pS176/180) IKKα/β and total IKKα and with GAPDH as a loading control. Biological replicate of data in <xref ref-type="fig" rid="fig2">Figure 2D</xref>. (<bold>D</bold>) Quantification of NF-κB nucleocytoplasmic ratios in d8 STOP and RAS treated for 45 min with conditioned media (CM) from either STOP or RAS cells grown in 4-OHT-containing media for 8 days. Data are from a biological replicate of experiment in <xref ref-type="fig" rid="fig2">Figure 2F</xref>. Statistical data are in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig2-figsupp1-data1-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig2-figsupp1-data2-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig2-figsupp1-v3.tif"/></fig></fig-group><p>Active NF-κB is phosphorylated at serine 536 (<xref ref-type="bibr" rid="bib57">Sakurai et al., 1999</xref>). Immunoblotting showed that, as expected, phosphorylation of NF-κB is increased in RAS cells compared with the STOP control cells. In RAS cells phosphorylation of NF-κB, but not total levels of NF-κB, decreased upon TPR knockdown (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Phosphorylation of the NF-κB kinase IKK, and total levels of IKKα, were also reduced in RAS cells upon TPR knockdown (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), further suggesting a reduction in NF-κB signalling pathway activation in senescent cells in the absence of TPR.</p><p>As TPR is part of the nuclear pore, it is possible that the knockdown of TPR causes a general defect in nuclear import, preventing activated NF-κB being imported into the nucleus upon OIS. To check that this is not the case, we treated control and RAS senescent cells with 4-OHT and siRNAs as before, then exposed them to conditioned media (CM) from either control or RAS cells 8 days post 4-OHT treatment (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). CM from senescent RAS cells is enriched in SASP factors which leads to NF-κB activation (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). Immunofluorescence showed that nuclear translocation of NF-κB occurs in RAS cells (with control siRNA) in the presence of CM from either STOP or RAS cells, because of their intrinsic activation of the SASP. In STOP cells, nuclear translocation of NF-κB was only induced by CM from RAS cells. This was not affected by TPR knockdown, and this was also the case for RAS cells after TPR knockdown (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Quantification of the NF-κB nucleocytoplasmic ratio confirms that TPR knockdown does not affect the nuclear import of NF-κB (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>).</p></sec><sec id="s2-3"><title>Decreased NF-κB activation upon TPR knockdown precedes the SASP</title><p>The SASP reinforces itself via a positive feedback loop – once secreted, SASP factors bind to receptors on the cell membrane, leading to NF-κB activation and increased SASP (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib2">Acosta et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Freund et al., 2010</xref>; <xref ref-type="bibr" rid="bib49">Orjalo et al., 2009</xref>). Therefore, the decreased NF-κB activation at d8 of RAS induction upon TPR knockdown could result from a general decrease in the SASP. To determine whether this was the case, we assessed NF-κB nuclear localisation at two earlier timepoints: day 3 (d3), which is before SASP induction and occurs when the cells are coming out of the initial highly proliferative state (<xref ref-type="bibr" rid="bib70">Young et al., 2009</xref>), and day 5 (d5), which is at the initial stages of the inflammatory SASP (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). There was no change in NF-κB nucleocytoplasmic ratio at d5 between any of the samples, and only a small increase between STOP siCTRL and RAS siCTRL at d3 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>), suggesting that these timepoints may be too early to observe significant NF-κB nuclear translocation. However, nuclear NF-κB intensity in the cell was increased in OIS-induced RAS cells compared with the control STOP cells at both d3 and d5, suggesting early NF-κB activation (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Knockdown of TPR led to significantly lower nuclear NF-κB intensities in RAS cells at both timepoints, suggesting early NF-κB signalling is reduced when OIS is induced in the absence of TPR. A small increase in NF-κB nuclear intensity in d3 STOP cells when TPR was knocked down and a small decrease at d5 were not reproducible (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Consistent with an effect on early NF-κB activation, immunoblotting showed that TPR knockdown resulted in decreased NF-κB phosphorylation (S536) in RAS cells at both d3 and d5 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), and decreased phosphorylation of IKK, the upstream kinase (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). There was no effect of TPR knockdown on total levels of IKKα at these early timepoints.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Decreased NF-κB activation upon TPR knockdown precedes the senescence-associated secretory phenotype (SASP).</title><p>(<bold>A</bold>) Schematic showing positive feedback loop in SASP signalling. Secreted IL-1α and IL-1β bind IL-1R1 at the cell membrane, leading to increased NF-κB activation and increased IL-1α and IL-1β secretion. (<bold>B</bold>) NF-κB immunostaining in control (STOP) and oncogene-induced senescence (OIS) (RAS) cells after 4-hydroxytamoxifen (4-OHT) and siRNA treatment for either 3 or 5 days. Scale bar: 10 μm. (<bold>C and D</bold>) Quantification of (<bold>C</bold>) nucleocytoplasmic ratios of NF-κB or (<bold>D</bold>) NF-κB nuclear intensity from experiment shown in (<bold>B</bold>). (<bold>n</bold>) indicates the number of cells analysed for each sample. Kruskal-Wallis testing was used to determine statistical significance followed by Dunn’s post hoc testing. n.s. p&gt;0.05, *&lt;0.05, ***&lt;0.001. (<bold>E</bold>) Immunoblots for phosphorylated (pS536) and total NF-κB (p65) in STOP and RAS cells treated with 4-OHT for 3 or 5 days and with control (CTRL) or TPR siRNAs. Vinculin was used as a loading control. Numbers below indicate the ratio of band intensity for NF-κBpS536 or NF-κB and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. (<bold>F</bold>) As in (<bold>E</bold>) but blotting to detect phosphorylated (pS176/180) IKKα/β and total IKKα. GAPDH was used as a loading control. Data from a biological replicate of the data in (<bold>A–E</bold>) are in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Statistical data are in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantification of NF-κB nucleocytoplasmic ratios, nuclear intensity, and statistical analysis for data in <xref ref-type="fig" rid="fig3">Figure 3C and D</xref> and for biological replicates in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>.</title><p>Median NF-κB nucleocytoplasmic ratios (n/c) and number of cells analysed for day 3 (d3) and d5 STOP or RAS cells subject to knockdown with control (CTRL) or TPR siRNAs. Kruskal-Wallis testing was used to determine statistical significance (p-value in parentheses) followed by Dunn’s post hoc testing. p-Values after Benjamini and Hochberg correction. NA: Kruskal-Wallis test showed no significant differences so it is not appropriate to carry out pairwise testing.</p></caption><media mimetype="application" mime-subtype="docx" xlink:href="elife-101702-fig3-data1-v3.docx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig3-data2-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig3-data3-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Decreased NF-κB activation upon TPR knockdown at days 3 and 5.</title><p>Related to <xref ref-type="fig" rid="fig3">Figure 3</xref>. (<bold>A and B</bold>) Quantification of (<bold>A</bold>) nucleocytoplasmic ratios of NF-κB or (<bold>B</bold>) nuclear NF-κB intensity from a biological replicate of the experiment shown in <xref ref-type="fig" rid="fig3">Figure 3B–D</xref>. (n) indicates the number of cells analysed for each sample. Kruskal-Wallis testing was used to determine statistical significance followed by Dunn’s post hoc testing. n.s. p&gt;0.05, *&lt;0.05, ***&lt;0.001. Statistical data are in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>. (<bold>C</bold>) Immunoblots for phosphorylated (pS536) and total NF-κB (p65) in STOP and RAS cells treated with 4-hydroxytamoxifen (4-OHT) for 3 or 5 days and with control (CTRL) or TPR siRNAs. Vinculin was used as a loading control. Numbers below indicate the ratio of band intensity for NF-κBpS536 or NF-κB and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. Biological replicate of data in <xref ref-type="fig" rid="fig3">Figure 3E</xref>. (<bold>D</bold>) As in (<bold>C</bold>) but blotting to detect phosphorylated (pS176/180) IKKα/β and total IKKα. GAPDH was used as a loading control. Biological replicate of data in <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig3-figsupp1-data1-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig3-figsupp1-data2-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig3-figsupp1-v3.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>TPR knockdown does not affect chromatin accessibility at day 3 (d3).</title><p>(<bold>A</bold>) Heatmap showing ATAC-seq signal in control (STOP) and oncogene-induced senescence (OIS) (RAS) cells 3 days after 4-hydroxytamoxifen (4-OHT) treatment and transfected with either CTRL or TPR siRNAs. Peak categories are those defined from the d8 ATAC-seq data in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. Intensity scale represents reads per kilobase per million mapped reads (RPKM). (<bold>B</bold>) Volcano plot of differential accessibility analysis of d3 ATAC-seq peaks in RAS siCTRL vs STOP siCTRL. The horizontal dashed line indicates an adjusted p-value (FDR) of 0.05. Peaks with a significant increase in accessibility in RAS cells are coloured pink if their accessibility does not change on siTPR treatment. Any peaks that did change would have been coloured blue as in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. (<bold>C</bold>) Heatmap showing ATAC-seq signal in control (STOP) and OIS (RAS) cells 3 days after 4-OHT treatment and transfected with either CTRL or TPR siRNAs. Peaks that gain accessibility in RAS cells are shown. Intensity scale represents RPKM. (<bold>D</bold>) HOMER motif analysis of the d3 RAS-specific ATAC-seq peaks. The top 10 motifs are shown for each category of peaks. All motifs have a p-value&lt;10<sup>–197</sup>. (<bold>E</bold>) Top ranking results of gene ontology analysis of genes close to d3 RAS-specific peaks using the Genomic Regions Enrichment of Annotations Tool (GREAT) package (<xref ref-type="bibr" rid="bib43">McLean et al., 2010</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig3-figsupp2-v3.tif"/></fig></fig-group><p>To determine whether, as at d8, lowered NF-κB activity upon TPR knockdown during early RAS activation (d3) is accompanied by changes in chromatin accessibility at the putative enhancers of SASP genes, we carried out ATAC-seq on STOP and RAS cells treated with 4-OHT for 3 days, as well as with control and TPR siRNAs. Whilst some of the accessible regions defined as senescence specific (SEN<sup>+</sup>) at d8 also show senescence-specific enhanced chromatin accessibility at d3, albeit less marked than at d8, SEN<sup>+</sup> accessibility peaks that were TPR-dependent (TPR<sup>+</sup>) at d8 did not show decreased chromatin accessibility upon TPR knockdown at d3 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). Indeed, we identified no TPR-dependent (TPR<sup>+</sup>) senescence-specific (SEN<sup>+</sup>) ATAC-seq peaks at d3 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B and C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Motif analysis showed that the d3 RAS-specific peaks were enriched for AP-1 binding motifs, similar to the d8 TPR<sup>+</sup>SEN<sup>+</sup> peaks (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>). This supports AP-1’s role as a pioneer TF in the senescence enhancer landscape (<xref ref-type="bibr" rid="bib42">Martínez-Zamudio et al., 2020</xref>). GO analysis showed that d3 RAS-specific peaks are in proximity to genes involved in SAHF regulation, as well as TGF-β signalling, which has been implicated in the early NOTCH1 regulated SASP (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E</xref>; <xref ref-type="bibr" rid="bib26">Hoare et al., 2016</xref>).</p><p>These data suggest that TPR plays a role in NF-κB activation during the early stages of stress in response to oncogenic RAS, before activation of the SASP and without affecting chromatin accessibility at regulatory elements.</p></sec><sec id="s2-4"><title>TPR knockdown during the early stages of OIS reduces STING expression and TBK1 activation in response to the stress induced by oncogenic RAS</title><p>Although we detect no changes in chromatin accessibility upon TPR knockdown at d3 of oncogenic stress, the decrease in NF-κB activation suggests that the initial signalling events leading to the loss of the SASP are already occurring. We therefore used RNA sequencing (RNA-seq) to investigate the transcriptional changes that could be driving the TPR-dependent decrease in NF-κB activation at d3.</p><p>Through its interaction with the TREX-2 complex, TPR is known to be required for the export of intronless and intron-poor mRNAs, as well as histone mRNAs, the majority of which are intronless (<xref ref-type="bibr" rid="bib4">Aksenova et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Lee et al., 2020</xref>). Indeed, of the genes downregulated on TPR knockdown, 14% (STOP) or 13% (RAS) are intronless (Fisher’s exact test, p=1.2 × 10<sup>–11</sup>; p=7.1 × 10<sup>–9</sup>, respectively) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). This includes histone genes (STOP cells: 3 genes, p=6.1 × 10<sup>–3</sup>; RAS cells: 6 genes, p=4.2 × 10<sup>–6</sup>) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p><p><italic>TPR</italic> was the most significantly downregulated gene when comparing siTPR with siCTRL in both RAS and STOP cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). To determine which changes in expression were specific to cells undergoing oncogenic stress, we compared RAS siTPR with RAS siCTRL, disregarding any genes that also changed in expression upon TPR knockdown in STOP cells. Interestingly, <italic>STING1</italic> showed the most significant RAS-specific decrease in expression (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Reduced <italic>STING1</italic> mRNA in RAS cells after 3 days of RAS induction and TPR knockdown was validated by RT-qPCR (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Immunoblotting did not reproducibly detect reduced levels of STING protein at d3 of RAS induction, perhaps due to protein stability at this short timepoint, but decreased levels were consistently detected by d5 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Decreased STING expression and TBK1 activation upon TPR knockdown during early stages of oncogene-induced senescence (OIS).</title><p>(<bold>A</bold>) Volcano plot of differential expression analysis of RNA isolated from RAS cells at day 3 (d3) of OIS and treated with siTPR vs siCTRL. Genes showing a significant change in expression in RAS, but not in STOP cells are indicated in green and the 10 most significant of these are labelled. Horizontal dashed line indicates an adjusted p-value (FDR) of 0.05. Axes are truncated for clarity so the change in <italic>TPR</italic> expression is not shown. (<bold>B</bold>) RT-qPCR for <italic>STING1</italic> mRNA in RNA prepared from STOP and RAS cells treated with 4-hydroxytamoxifen (4-OHT) for 3 days and with control (siCTRL) and TPR siRNAs. Expression is relative to STOP cells treated with siCTRL and normalised to levels of <italic>GAPDH</italic> mRNA. Individual data points are the mean of three technical replicates for each of four biological replicates. Statistical data are in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>. (<bold>C</bold>) Immunoblots detecting STING in STOP and RAS cells treated with 4-OHT for 3 or 5 days and with control (siCTRL) or TPR siRNAs. Vinculin was used as a loading control. Numbers below indicate the ratio of band intensity for STING and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. (<bold>D</bold>) ELISA for 2’3’-cGAMP in STOP and RAS cells treated with 4-OHT for 5 days and with control (siCTRL) or TPR siRNAs. cGAMP concentration was normalised to total protein concentration calculated using BCA assay. Statistical data are in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>. *p&lt;0.05. (<bold>E</bold>) As in (<bold>C</bold>) but detecting phosphorylated TBK1 (pS172) in STOP and RAS cells at d5 of OIS. GAPDH was used as a loading control. Data from biological replicates for (<bold>C</bold>) and (<bold>E</bold>) are in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Statistical analysis for <italic>STING1</italic> qPCR data in <xref ref-type="fig" rid="fig4">Figure 4B</xref> and for cGAMP ELISA data in <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title><p>One-way ANOVA was used to determine statistical significance followed by Šídák’s multiple comparisons test.</p></caption><media mimetype="application" mime-subtype="docx" xlink:href="elife-101702-fig4-data1-v3.docx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig4-data2-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Decreased abundance of mRNAs for intronless genes and for <italic>STING1</italic> in RAS cells upon TPR knockdown at day 3 (d3).</title><p>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>A</bold>) Volcano plots of differential expression analysis of d3 STOP (top) and RAS (bottom) cells treated with TPR vs CTRL siRNAs with intronless genes coloured pink. Horizontal dashed line indicates an adjusted p-value (FDR) of 0.05. Axes are truncated for clarity so change in expression for TPR is not shown. Fisher’s exact test (p) was carried out to determine whether the number of downregulated intronless genes was greater than expected by chance. (<bold>B</bold>) As in (<bold>A</bold>) but with histone genes labelled in blue. (<bold>C</bold>) Volcano plot showing differential expression analysis comparing siTPR vs siCTRL in d3 STOP (top) or RAS (bottom) cells. Blue dots indicate differentially expressed genes and the dashed horizontal line indicates an adjusted p-value of 0.05. The 10 genes with the most significant p-values are labelled. (<bold>D</bold>) Immunoblots detecting STING in STOP and RAS cells treated with 4-hydroxytamoxifen (4-OHT) for 3 or 5 days and with control (siCTRL) or TPR siRNAs. Vinculin was used as a loading control. Numbers below indicate the ratio of band intensity for STING and the vinculin loading control with the ratio for RAS siCTRL normalised to 1.00. Biological replicate of the data in <xref ref-type="fig" rid="fig4">Figure 4C</xref>. (<bold>E</bold>) As in (<bold>D</bold>) but detecting phosphorylated TBK1 (pS172) in STOP and RAS cells at d5 of oncogene-induced senescence (OIS). GAPDH was used as a loading control. Biological replicate of the data in <xref ref-type="fig" rid="fig4">Figure 4D</xref>. (<bold>F</bold>) Log-transformed RNA sequencing (RNA-seq) counts for RNAs transcribed from transposable elements comparing (left) RAS vs STOP cells at d3 and treated with control siRNAs; (middle) d3 STOP cells treated with control vs TPR siRNAs; (right) d3 RAS cells treated with control vs TPR siRNAs. Transposable elements with absolute fold changes&gt;1.5 and adjusted p-values&lt;0.05 are highlighted in red and labelled.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Uncropped and labelled gels for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-101702-fig4-figsupp1-data1-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig4-figsupp1-v3.tif"/></fig></fig-group><p>The cGAS-STING pathway is known to activate the SASP via NF-κB signalling (<xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Glück et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Yang et al., 2017</xref>). cGAS-STING detects dsDNA in the cytoplasm, with DNA binding leading to production of 2′3′ cyclic GMP-AMP (cGAMP), a potent STING agonist. However, cGAS-independent STING activation has also been reported (<xref ref-type="bibr" rid="bib64">Unterholzner and Dunphy, 2019</xref>). We assayed the production of cGAMP in STOP and RAS cells and upon TPR knockdown by ELISA (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). cGAMP was significantly elevated in RAS compared with STOP cells. TPR knockdown in RAS cells appeared to result in decreased cGAMP, though this did not reach statistical significance (<xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>).</p><p>TANK-binding kinase 1 (TBK1) acts downstream of STING-mediated sensing of cytosolic DNA, and controls NF-κB signalling. TBK1 is phosphorylated at serine 172 when active (<xref ref-type="bibr" rid="bib1">Abe and Barber, 2014</xref>; <xref ref-type="bibr" rid="bib60">Shu et al., 2013</xref>). To investigate whether TPR is required for activation of this pathway early in OIS, we therefore analysed TBK1 phosphorylation. Immunoblotting showed decreased TBK1 phosphorylation in RAS cells upon TPR knockdown at d5 of RAS induction (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). Together, these data are consistent with TPR knockdown blunting STING activation, likely involving cGAS-dependent cytosolic DNA sensing.</p><p>The transcription of several classes of retrotransposons, including long-interspersed element-1 (LINE1) and human endogenous retroviruses (HERVs), is known to be activated in senescent cells, and sensed through cGAS triggering an innate immune response (<xref ref-type="bibr" rid="bib13">De Cecco et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Liu et al., 2023</xref>). Although RNA abundance for some transposable elements, including HERV and LINE1 elements, was higher in RAS compared with STOP cells treated with control siRNA, there were no significant changes in transposable element RNA abundance upon knockdown of TPR in either cell line (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). This suggests that it is not a change in transposable element expression that drives the decrease in innate immune signalling seen upon TPR knockdown at d3 of OIS.</p></sec><sec id="s2-5"><title>TPR and HMGA1 are required for the formation of CCFs during the early stages of OIS</title><p>Another trigger of innate immune activation in senescent cells is the generation of CCFs (<xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Glück et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Yang et al., 2017</xref>). To determine whether TPR affects CCF generation, we assessed their frequency – as evidenced by the proportion of cells with DAPI-stained foci in the cytoplasm not obviously connected to the nucleus - at d3 and d5 of RAS induction. The frequency of detectable CCFs decreased when TPR was knocked down. Though apparent by d3, this was only statistically significant at d5 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>TPR and HMGA1 are required for the induction of cytoplasmic chromatin fragments (CCFs) during the early phase of oncogene-induced senescence (OIS).</title><p>(<bold>A</bold>) Mean percentage of cells containing CCFs in STOP and RAS cells at day 3 (d3) or d5 of OIS and treated with either control (siCTRL) or TPR siRNAs. Data points are for three biological replicates. Data were fitted to a generalised linear model before carrying out pairwise comparisons between samples. n.s. p&gt;0.05, *&lt;0.05, ***&lt;0.001. (<bold>B</bold>) Immunostaining for H3K9me3 and H3K27me2/3 in a DAPI-stained d5 RAS cell with a CCF. Scale bar: 10 μm. (<bold>C</bold>) As in (<bold>B</bold>) but in d5 RAS cells containing CCFs and staining for γH2AX and either TPR (top) or POM121 (bottom). Scale bar: 10 μm. (<bold>D</bold>) Mean percentage of CCFs that show +ve or -ve staining for POM121 or γ-H2AX in d5 RAS cells. Data are from two biological replicates (n=49 and 67 CCFs). (<bold>E</bold>) Mean percentage of CCFs that show +ve or -ve staining for TPR or γ-H2AX in d5 RAS cells. Data are from two biological replicates (n=56 and 36 CCFs). (<bold>F</bold>) TPR and HMGA1 immunostaining in control (STOP) and OIS (RAS) cells after 4-hydroxytamoxifen (4-OHT) and siRNA (control, TPR and HMGA1) treatment for 5 days. Scale bar: 10 µm. (<bold>G</bold>) Mean percentage of cells containing senescence-associated heterochromatic foci (SAHF) in STOP and RAS cells at d5 of OIS and treated with either control (siCTRL), TPR, or HMGA1 siRNAs. Data points are for four biological replicates. Data were fitted to a generalised linear model before carrying out pairwise comparisons between samples. *** p&lt;0.001. (<bold>H</bold>) Mean percentage of cells containing CCFs in cells treated as in (<bold>G</bold>). Data points are for four biological replicates. Data were fitted to a generalised linear model before carrying out pairwise comparisons between samples. n.s. p&gt;0.05, *&lt;0.05, ***&lt;0.001. Statistical data from (<bold>A–G</bold>) are in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Statistical analysis for cytoplasmic chromatin fragments (CCF) and senescence-associated heterochromatic foci (SAHF) data in <xref ref-type="fig" rid="fig5">Figure 5A, G, and H</xref>.</title><p>Data were fitted to a generalised linear model before carrying out pairwise comparisons between samples. 500 cells were assessed per sample for each replicate of each experiment.</p></caption><media mimetype="application" mime-subtype="docx" xlink:href="elife-101702-fig5-data1-v3.docx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-fig5-v3.tif"/></fig><p>CCFs form from blebbing off of the nuclear membrane, thought to result from loss of structural integrity of the nuclear envelope (<xref ref-type="bibr" rid="bib28">Ivanov et al., 2013</xref>). CCFs are known to contain lamin B1 (<xref ref-type="bibr" rid="bib14">Dou et al., 2015</xref>) but whether they contain other components of the nuclear envelope is unexplored. By immunostaining we confirmed that, as expected, CCFs are positive for the heterochromatic histone marks H3K9me3 and H3K27me3 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) and for γ-H2AX (<xref ref-type="bibr" rid="bib14">Dou et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref>). However, they appear to lack staining for TPR or for POM121, a transmembrane nucleoporin, suggesting that there are no nuclear pores in the CCF envelope (<xref ref-type="fig" rid="fig5">Figure 5C–E</xref>).</p><p>The requirement of TPR for CCF formation during OIS could be a direct consequence of events occurring at the nuclear basket, or could be due to the failure to relocate heterochromatin from the nuclear periphery to internal SAHF when TPR is depleted (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). To distinguish these two scenarios we examined the consequence of HMGA1 knockdown on CCF formation during OIS. HMGA1 is a small AT-rich DNA binding protein abundant in chromatin, that localises to SAHF during OIS. Moreover, depletion of HMGA1 also abrogates SAHF formation (<xref ref-type="bibr" rid="bib46">Narita et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Olan et al., 2024</xref>). Therefore, we used siRNA to knock down HMGA1 during OIS in RAS cells and examined the effect on CCF formation. Consistent with previous reports, knockdown of HMGA1 in RAS cells led to a significant loss of SAHF compared to control knockdown, and to a greater extent than seen for TPR knockdown (<xref ref-type="fig" rid="fig5">Figure 5F–G</xref>). HMGA1 depletion was accompanied by a decrease in CCF frequency at d5 similar to that which occurs on TPR knockdown (<xref ref-type="fig" rid="fig5">Figure 5H</xref>, <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). These data suggest that the decrease in CCF is linked to changes in heterochromatin organisation, i.e., SAHF formation and not to changes at the nuclear pore basket per se.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have previously linked TPR at the nuclear basket to the re-organisation of heterochromatin away from the nuclear periphery to form SAHF, and to the activation of SASP genes, during the process of OIS (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). The extent to which these events are coupled was unclear. In this study, we address this by looking at the effects of depleting TPR very early (d3) following the induction of oncogenic RAS, as the cells are responding to the initial stress and before SASP gene transcriptional induction (<xref ref-type="bibr" rid="bib70">Young et al., 2009</xref>).</p><p>We show that TPR loss during OIS (d8) prevents chromatin opening at putative SASP gene enhancers enriched in binding motifs for NF-κB – a key TF that drives the SASP. However, we show that TPR is also required for the very early stages of NF-κB activation upon RAS oncogenic stress, well before SASP gene activation, suggesting that TPR does not have a direct effect on chromatin structure at enhancers of the SASP. Rather, our data suggest that TPR loss has its impact upstream of NF-κB and its translocation to the nucleus, by decreasing TBK1 phosphorylation, likely downstream of cGAS-STING signalling. We link this to the production of CCFs – the number of CCFs decreases when TPR is knocked down.</p><p>Cytoplasmic chromatin derived from the nuclear genome is known to activate the innate immune response, sensed and signalled through cGAS-STING upstream of TBK1. Cytoplasmic DNA sensing is best studied in the context of micronuclei, formed during mitosis as a consequence of unrepaired DNA damage (<xref ref-type="bibr" rid="bib44">Miller et al., 2021</xref>). Micronuclei can contain many different types of chromatin (<xref ref-type="bibr" rid="bib40">Mammel et al., 2022</xref>) and have been reported to have NPCs in their membrane, albeit at a much lower density than the primary nuclear membrane (<xref ref-type="bibr" rid="bib12">Crasta et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Hatch et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Liu et al., 2018</xref>). In contrast, we could not detect a core nuclear pore component (POM121), or TPR, in CCFs, consistent with a mechanism of formation that is distinct from that of micronuclei. This suggests that either the CCFs are formed from the nuclear membrane between NPCs or that NPCs are rapidly lost from CCFs.</p><p>CCFs form by blebbing off from the nuclear periphery (<xref ref-type="bibr" rid="bib28">Ivanov et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Miller et al., 2021</xref>) and preferentially contain chromatin fragments enriched in the heterochromatin histone modifications (H3K9me3 and H3K27me3) that are abundant in lamina-associated domains at the nuclear periphery (<xref ref-type="bibr" rid="bib21">Guelen et al., 2008</xref>). TPR has been suggested to interact with, and affect the organisation of, lamin B1 at the nuclear periphery (<xref ref-type="bibr" rid="bib16">Fišerová et al., 2019</xref>) and there is loss of lamin B1 from the nuclear periphery in senescence (<xref ref-type="bibr" rid="bib14">Dou et al., 2015</xref>; <xref ref-type="bibr" rid="bib18">Freund et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Sadaie et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Shimi et al., 2011</xref>). Therefore, it is possible that TPR depletion impacts CCF formation through its effects on lamin B1. However, here we also show decreased CCF formation in OIS RAS cells following knockdown of HMGA1 – a chromatin protein bound throughout the genome (<xref ref-type="bibr" rid="bib48">Olan et al., 2024</xref>) and not a component of the nuclear periphery per se. Like TPR, HMGA1 is also required for heterochromatin re-organisation into SAHF during OIS (<xref ref-type="fig" rid="fig5">Figure 5</xref>; <xref ref-type="bibr" rid="bib46">Narita et al., 2006</xref>). Therefore our data suggest that CCF formation is linked to the loss of heterochromatin from the nuclear periphery and the formation of SAHF during OIS. Heterochromatin is stiffer and more resistant to deformation than euchromatin (<xref ref-type="bibr" rid="bib19">Ghosh et al., 2021</xref>) and decreasing heterochromatin by inhibiting histone deacetylases has been shown to increase nuclear blebbing (<xref ref-type="bibr" rid="bib61">Stephens et al., 2018</xref>). We therefore consider it likely that the decrease in CCFs produced during the early phases of OIS upon TPR, or HMGA1, knockdown is caused by an increase in the stability of the nuclear periphery due to the heterochromatin that remains there when SAHF are not formed.</p><p>Together, our results suggest a role for TPR as an important factor in the loss of nuclear integrity that occurs in response to oncogene-induced stress, leading directly to activation of cytoplasmic nucleic acid sensing and the key inflammatory gene expression programme of senescence. Whether TPR has a similar role for other triggers of senescence and in aging remains to be determined.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Cell culture, CM preparation, and siRNA transfection</title><p>IMR90 cells were cultured in DMEM with 10% FBS and 1% penicillin/streptomycin in a 37°C incubator with 5% CO<sub>2</sub>. IMR90 cells were infected with pLNC-ER:RAS and pLXS-ER:STOP retroviral vectors to produce RAS and STOP cells respectively (<xref ref-type="bibr" rid="bib3">Acosta et al., 2013</xref>). RAS translocation to the nucleus was induced by addition of 100 nM 4-OHT (Sigma). The cell lines tested negative for mycoplasma contamination and their identity is confirmed by their genomic sequence present in ATAC-seq data and their growth response to 4OH. 4-OHT-containing medium was changed every 3 days.</p><p>To prepare CM, 5×10<sup>5</sup> STOP and RAS cells were grown in 100 nM 4-OHT media for 8 days. After 4 days this was replaced with media with 0.1% FCS and 100 nM 4-OHT. Media was harvested on d8. To activate NF-κB, cells were treated with the CM for 45 min.</p><p>siRNA knockdown was carried out as previously described (<xref ref-type="bibr" rid="bib5">Boumendil et al., 2019</xref>). Briefly, 9×10<sup>5</sup> STOP or RAS IMR90 cells (except for imaging experiments, which used 1.5×10<sup>5</sup> cells) were transfected using Dharmafect transfection reagent (Dharmacon) with a 30 nM final concentration of control (siCTRL, D-001810-10-59), TPR (siTPR, L-010548-00) or HMGA1 (siHMGA1, L-004597-00) siRNA pools (Dharmacon). Transfections were carried out on d0 of 4-OHT treatment and on every third subsequent day.</p></sec><sec id="s4-2"><title>Immunofluorescence</title><p>Cells were seeded onto coverslips 48 hr before fixation with 4% paraformaldehyde in PBS for 30 min at room temperature, before permeabilisation with 0.2% Triton X-100 for 10 min. Coverslips were then washed three times with PBS before blocking in 1% bovine serum albumin (BSA) for 30 min. Coverslips were then incubated for 45 min in a humid chamber with primary antibody diluted in 1% BSA at the dilutions detailed in the Key resources table. Coverslips were washed three times with PBS. Cells were then incubated with fluorescently labelled secondary antibodies (Life Technologies, Key resources table) for 30 min followed by two washes in PBS. Finally, PBS with 50 ng/ml DAPI was added for 4 min, before a final wash with PBS and mounting onto slides with VectaShield (Vector Laboratories).</p><p>Epifluorescence images were acquired using either a Photometrics Coolsnap HQ2 CCD camera (Teledyne Photometrics) or a Hamamatsu Orca Flash 4.0 CMOS camera on a Zeiss Axioplan II fluorescence microscope with Plan-neofluar/apochromat objective lenses (Carl Zeiss UK), a Mercury Halide fluorescent light source (Exfo Excite 120, Excelitas Technologies) and Chroma #83000 triple band pass filter set (Chroma Technology Corp.) with the single excitation and emission filters installed in motorised filter wheels (Prior Scientific Instruments). Image capture was performed using Micromanager (Version 1.4). For the CM experiment (<xref ref-type="fig" rid="fig2">Figure 2</xref>) images were acquired using a Photometrics Prime BSI CMOS camera (Teledyne Photometrics) fitted to a Zeiss AxioImager M2 fluorescence microscope with Plan-Apochromat objectives, a Zeiss Colibri 7 LED light source, together with Zeiss filter sets 90 HE, 92 HE, 96 HE, 38 HE, and 43 HE (Carl Zeiss UK). Image capture was performed in Zeiss Zen 3.5 software.</p></sec><sec id="s4-3"><title>Image analysis</title><p>Nuclear NF-κB intensity and nucleocytoplasmic ratios were calculated using CellProfiler (<xref ref-type="bibr" rid="bib62">Stirling et al., 2021</xref>). Nuclei were identified in the DAPI channel using the Identify Primary Objects module to carry out adaptive Otsu thresholding with a threshold smoothing scale of 5, a threshold correction factor of 0.37, a 200-pixel adaptive window, and a typical object diameter of 100–500 pixels. Clumped objects were distinguished using the ‘Intensity’ method and dividing lines were drawn between clumped objects using the ‘Shape’ method. A secondary object was then generated by expanding the primary object by 50 pixels, and NF-κB intensity measured for the primary object (nucleus) and secondary object (nucleus+the cytoplasmic regions immediately surrounding the nucleus). A tertiary object (cytoplasm) was generated by removing the primary object area from the secondary object. Nucleocytoplasmic ratio was calculated by dividing the NF-κB intensity in the cytoplasm by the nuclear NF-κB intensity.</p><p>To count CCFs, 500 cells per sample were observed by epifluorescence microscopy and cells displaying cytoplasmic DAPI staining were imaged. One blinded replicate was carried out by SB who was unfamiliar with previous results. For quantification of CCFs with γ-H2AX, TPR, and POM121 staining, all cells on a slide of d5 OIS RAS cells were assessed and imaged if they displayed cytoplasmic DAPI staining.</p></sec><sec id="s4-4"><title>Immunoblotting</title><p>Cells were lysed in Cell Lysis Buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM Na<sub>2</sub>EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 μg/ml leupeptin, Cell Signaling Technology) with one Pierce Phosphatase and Protease Inhibitor Mini Tablet (Thermo Fisher) added per ml of cell lysate. Protein concentration was quantified using a Pierce BCA protein analysis kit (Thermo Fisher), and then 20 μg of protein was run on NuPage 4–12% Bis-Tris gels (Thermo Fisher) at 150 V for 1 hr. After transfer onto nitrocellulose membranes with an iBlot 2 gel transfer device (Thermo Fisher), membranes were blocked in 5% BSA in TBS with 0.1% Tween-20 (TBS-T) for 30 min then incubated overnight with the primary antibodies at the dilutions detailed in the Key Resources table, in 5% BSA in TBS-T. After 3×10 min washes in TBS-T, membranes were incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies, before three further washes with TBS-T. Membranes were imaged using an Amersham ImageQuant 800 imager (Cytiva) on the chemiluminescence setting with the SuperSignal West Femto maximum sensitivity substrate kit (Thermo Fisher). When using the mouse anti-β-actin-HRP antibody, the primary antibody incubation step was omitted and a 10 min incubation carried out alongside the secondary antibody step for other blots, before washing and imaging as before.</p><p>Quantification of immunoblots was carried out using Fiji (<xref ref-type="bibr" rid="bib58">Schindelin et al., 2012</xref>). Band intensity was normalised to background intensity and the ratio of the band intensity for the protein of interest divided by the loading control was calculated.</p></sec><sec id="s4-5"><title>2’3’-cGAMP ELISA</title><p>2′3′-cGAMP was assayed using the 2′3′-cGAMP ELISA Kit (catalog no. 501700; Cayman Chemical) according to the manufacturer’s instructions. Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% sodium deoxycholate, 0.03% SDS, 0.5 mM Na<sub>2</sub>EDTA, 0.005% Triton X-100, 1 mM MgCl<sub>2</sub>, 25 kU benzonase). Each sample was assayed in duplicate. The plate was read at a wavelength of 450 nm. The relative amount of 2′3′-cGAMP was determined by interpolating the intensity values to the standard curve and normalising by total protein concentration, which was determined using a Pierce BCA protein analysis kit (Thermo Fisher).</p></sec><sec id="s4-6"><title>ATAC-seq library preparation</title><p>A standard ATAC-seq protocol with IMR90 cells yielded too many mitochondrial reads and high PCR duplication levels because of poor tagmentation. To circumvent this issue, we used the Omni-ATAC protocol (<xref ref-type="bibr" rid="bib11">Corces et al., 2017</xref>) with some modifications. Briefly, IMR90 cells were harvested by trypsinisation and washed with cold PBS. One million cells were resuspended in ice-cold ATAC resuspension buffer (ATAC-RSB; 20 mM Tris-HCl pH 7.6, 10 mM MgCl<sub>2</sub>, 20% dimethyl formamide) and 40 strokes in a 1 ml Dounce using a rounded pestle were applied. Debris was pre-cleared by spinning at 100×<italic>g</italic> for 3 min. The supernatant was collected and spun again at 1000×<italic>g</italic> for 5 min to collect the nuclear pellet. The pellet was resuspended in 1 ml ATAC-RSB buffer with 0.1% Tween-20 and spun at 1000×<italic>g</italic> for 5 min. The nuclear pellet was resuspended in 100 μl TD buffer (10 mM Tris-HCl pH 7.6, 5 mM MgCl<sub>2</sub>, 10% dimethyl formamide) and the Omni-ATAC protocol performed on 5×10<sup>4</sup> nuclei. ATAC-seq libraries were made using adaptor sequences as described previously (<xref ref-type="bibr" rid="bib7">Buenrostro et al., 2013</xref>). Libraries were assessed for quality and fragment size using the Agilent Bioanalyzer. Sequencing was performed on the NextSeq 2000 platform (Illumina) using NextSeq 1000/2000 P2 Reagents.</p></sec><sec id="s4-7"><title>ATAC-seq data analysis</title><p>FastQC was used to obtain basic quality control metrics from sequencing data and to assess the quality of reads before preprocessing steps. Sequencing reads were trimmed to a minimum of 30 bases and adaptor sequences clipped using cutadapt (<xref ref-type="bibr" rid="bib41">Martin, 2011</xref>). Reads were aligned to the human genome assembly hg19 using bowtie2 (<xref ref-type="bibr" rid="bib34">Langmead and Salzberg, 2012</xref>). Mitochondrial reads and PCR duplicates were filtered out before shifting reads by +4 bp for the positive strand and –5 bp for the negative strand. Peaks were then called using MACS2 (<xref ref-type="bibr" rid="bib71">Zhang et al., 2008</xref>) before removing all peaks from promoter regions, as we were specifically interested in promoter-distal regulatory elements. The HOMER (<xref ref-type="bibr" rid="bib25">Heinz et al., 2010</xref>) functions makeTagDirectory and annotatePeaks.pl with settings ‘-noadj -len 0 -size given’ were used for read counting before count tables were loaded into RStudio.</p><p>Trimmed mean of M-values normalisation was carried out using edgeR (<xref ref-type="bibr" rid="bib54">Robinson et al., 2010</xref>) and analysis of differentially accessible regions was carried out using limma (<xref ref-type="bibr" rid="bib53">Ritchie et al., 2015</xref>). Contrasts were designed as ~0 + Sample, where Sample specifies both the cell line and siRNA treatment. A cut-off adjusted p-value of 0.05 was used to define differentially accessible peaks. Heatmaps were generated using the deepTools function plotHeatmap (<xref ref-type="bibr" rid="bib52">Ramírez et al., 2016</xref>). Analysis of nearby genes was carried out using GREAT (<xref ref-type="bibr" rid="bib43">McLean et al., 2010</xref>) with the ‘basal plus extension’ setting. Motif analysis was carried out using HOMER (<xref ref-type="bibr" rid="bib25">Heinz et al., 2010</xref>).</p></sec><sec id="s4-8"><title>Analysis of published ChIP-seq data</title><p>NarrowPeak files for H3K27 acetylation ChIP-seq from growing and senescent IMR90 RAS<sup>G12V</sup> cells (<xref ref-type="bibr" rid="bib50">Parry et al., 2018</xref>) were obtained from the Gene Expression Omnibus with accession number GSE103590. Correlation between replicates was checked using the plotCorrelation function from the deepTools package (<xref ref-type="bibr" rid="bib52">Ramírez et al., 2016</xref>). Heatmaps were generated by using the deepTools function plotHeatmap to plot the first replicate from each sample with peak categories taken from the ATAC-seq analysis.</p></sec><sec id="s4-9"><title>RT-qPCR</title><p>Total RNA was extracted using the RNeasy mini kit (QIAGEN) and cDNAs generated using SuperScript II (Life Technologies). Real-time PCR was performed on a Bio-Rad CFX Touch using SYBR Green PCR master mix (Roche) and primers for STING1 (Fwd; <named-content content-type="sequence">ATATCTGCGGCTGATCCTGC</named-content>, Rev; <named-content content-type="sequence">TTGTAAGTTCGAATCCGGGC</named-content>) and GAPDH (Fwd; <named-content content-type="sequence">CAGCCTCAAGATCATCAGCA</named-content>, Rev; <named-content content-type="sequence">TGTGGTCATGAGTCCTTCCA</named-content>). Samples were heated at 95°C for 5 min before 44 cycles of 10 s at 95°C, 10 s at 60°C, 20 s at 72°C. Expression was normalised to <italic>GAPDH</italic>.</p></sec><sec id="s4-10"><title>RNA-seq library preparation and analysis</title><p>Total RNA was extracted using the RNeasy mini kit (QIAGEN). Library preparation was carried out by the Edinburgh Clinical Research Facility from 500 ng of each RNA sample using the NEBNext Ultra II Directional RNA library kit with PolyA enrichment module (New England Biolabs). Libraries were assessed for quality and fragment size using the Agilent Bioanalyzer. Sequencing was performed on the NextSeq 2000 platform (Illumina) using NextSeq 1000/2000 P2 Reagents.</p><p>FastQC was used to obtain basic quality control metrics from sequencing data and to assess the quality of reads. For each sample, raw Fastq files were merged and aligned to the genome (hg19) using HISAT2 (<xref ref-type="bibr" rid="bib31">Kim et al., 2019</xref>). Alignment statistics were calculated using GATK (<xref ref-type="bibr" rid="bib65">Van der Auwera and O’Connor, 2020</xref>). Reads were assigned to genomic features using the featureCounts tool from the subread package (<xref ref-type="bibr" rid="bib36">Liao et al., 2014</xref>).</p><p>Differential expression analysis between each set of conditions was carried out using DESeq2 (<xref ref-type="bibr" rid="bib39">Love et al., 2014</xref>). Contrasts were carried out between samples, where the sample specifies both the cell line and siRNA treatment. GO analysis was carried out using clusterProfiler (<xref ref-type="bibr" rid="bib67">Wu et al., 2021</xref>). Volcano plots were rendered using ggplot2 (<xref ref-type="bibr" rid="bib66">Wickham, 2016</xref>). A list of intronless genes was obtained from the hg19 GTF file available from UCSC (<xref ref-type="bibr" rid="bib47">Nassar et al., 2023</xref>) by sorting for genes with a single exon. A list of histone genes was obtained from HGNC (<xref ref-type="bibr" rid="bib6">Braschi et al., 2019</xref>).</p><p>For the analysis of transposable element expression, raw reads were aligned to the human genome assembly hg38 using HISAT2 (<xref ref-type="bibr" rid="bib31">Kim et al., 2019</xref>). Alignment files were processed using the TEcounts tool from the TEtranscripts pipeline (<xref ref-type="bibr" rid="bib29">Jin et al., 2015</xref>). Resulting transposable element and gene raw counts were then subjected to the variance stabilising transformation in DESeq2 (<xref ref-type="bibr" rid="bib39">Love et al., 2014</xref>) and analysed for differential expression with default settings.</p></sec><sec id="s4-11"><title>Statistics</title><p>Statistical analysis was performed using R and the specific statistical tests used are described in the relevant text, source data, and figure legends. p-Value significance is denoted on figures as follows: *&lt;0.05, **&lt;0.01, ***&lt;0.001.</p></sec><sec id="s4-12"><title>Data availability</title><p>RNA-seq and ATAC-seq data generated in this study have been deposited at NCBI GEO GSE264387 and GSE264390, respectively.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Methodology</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b, and c</xref> are tables summarising data in the manuscript.</title><p>(a) Table summarising day 8 ATAC-seq changes in peak accessibility. Number of ATAC-peaks with significant changes generated from comparisons between samples using the limma package with an adjusted p-value cut-off of 0.05. Peaks significantly upregulated in RAS siCTRL compared to STOP siCTRL (SEN<sup>+</sup>) were further divided into TPR-dependent (SEN<sup>+</sup>TPR<sup>+</sup>) and TPR-independent (SEN<sup>+</sup>TPR<sup>-</sup>) as shown. (b) Table indicating the proximity of senescence-associated secretory phenotype (SASP) gene promoters to TPR-dependent, senescence-dependent ATAC-seq peaks. Distance (in bp) between TPR<sup>+</sup>SEN<sup>+</sup> ATAC-seq peaks from the transcription start site (TSS) of genes involved in positive regulation of the inflammatory response, cytokine activity, and cytokine receptors. (c) Table summarising day 3 ATAC-seq changes in peak accessibility. Number of peaks with significant changes generated from comparisons between samples using the limma package with an adjusted p-value cut-off of 0.05.</p></caption><media xlink:href="elife-101702-supp1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-101702-mdarchecklist1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The RNA-seq and ATAC-seq data generated in this study have been deposited in NCBI GEO under Accession numbers GSE264387 and GSE264390, respectively.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>TPR is required for cytoplasmic chromatin fragment formation during senescence</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264387">GSE264387</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>TPR is required for cytoplasmic chromatin fragment formation during senescence</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264390">GSE264390</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Parry</surname><given-names>AJ</given-names></name><name><surname>Hoare</surname><given-names>M</given-names></name><name><surname>Bihary</surname><given-names>D</given-names></name><name><surname>Hänsel-Hertsch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>H3K27ac ChIP-seq</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103590">GSE103590</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the Edinburgh Clinical Research Facility for RNA-seq library preparation and for the sequencing of RNA-seq and ATAC-seq libraries, and the IGC Advanced Imaging facility for their help in fluorescence imaging and image analysis. We are grateful to Marie-Therese El-Daher, IGC, for help with ELISA. Funding Statement: BMB was supported a PhD studentship from the Medical Research Council. YK and WAB were supported by a Wellcome Trust Investigator Award 217120/Z/19/Z. Work in the WAB lab is funded by MRC University Unit grants MC_UU_00007/2 and MC_UU_00035/7. JCA acknowledges funding by Cancer Research UK (CRUK) (C47559/A16243 Training &amp; Career Development Board – Career Development Fellowship), the University of Edinburgh-MRC Chancellor’s Fellowship, the Ministry of Science and Innovation of the Government of Spain (Proyecto PID2020-117860GB-I00 ﬁnanced by MCIN/ AEI /10.13039/501100011033) and the Spanish National Research Council (CSIC). Work in the laboratory of CB is supported by the Centre national de la recherche scientifique (CNRS), the Agence Nationale de la Recherche (ANR), under grant number ANR-21-CE12-0039 (project NPCOS), and the French State within the Plan d’investissements France 2030 (program LabUM EpiGenMed, project ChOICe).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Barber</surname><given-names>GN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1</article-title><source>Journal of Virology</source><volume>88</volume><fpage>5328</fpage><lpage>5341</lpage><pub-id pub-id-type="doi">10.1128/JVI.00037-14</pub-id><pub-id pub-id-type="pmid">24600004</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>JC</given-names></name><name><surname>O’Loghlen</surname><given-names>A</given-names></name><name><surname>Banito</surname><given-names>A</given-names></name><name><surname>Guijarro</surname><given-names>MV</given-names></name><name><surname>Augert</surname><given-names>A</given-names></name><name><surname>Raguz</surname><given-names>S</given-names></name><name><surname>Fumagalli</surname><given-names>M</given-names></name><name><surname>Da Costa</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Popov</surname><given-names>N</given-names></name><name><surname>Takatsu</surname><given-names>Y</given-names></name><name><surname>Melamed</surname><given-names>J</given-names></name><name><surname>d’Adda di Fagagna</surname><given-names>F</given-names></name><name><surname>Bernard</surname><given-names>D</given-names></name><name><surname>Hernando</surname><given-names>E</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Chemokine signaling via the CXCR2 receptor reinforces senescence</article-title><source>Cell</source><volume>133</volume><fpage>1006</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.03.038</pub-id><pub-id pub-id-type="pmid">18555777</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>JC</given-names></name><name><surname>Banito</surname><given-names>A</given-names></name><name><surname>Wuestefeld</surname><given-names>T</given-names></name><name><surname>Georgilis</surname><given-names>A</given-names></name><name><surname>Janich</surname><given-names>P</given-names></name><name><surname>Morton</surname><given-names>JP</given-names></name><name><surname>Athineos</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>TW</given-names></name><name><surname>Lasitschka</surname><given-names>F</given-names></name><name><surname>Andrulis</surname><given-names>M</given-names></name><name><surname>Pascual</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>KJ</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Dharmalingam</surname><given-names>G</given-names></name><name><surname>Snijders</surname><given-names>AP</given-names></name><name><surname>Carroll</surname><given-names>T</given-names></name><name><surname>Capper</surname><given-names>D</given-names></name><name><surname>Pritchard</surname><given-names>C</given-names></name><name><surname>Inman</surname><given-names>GJ</given-names></name><name><surname>Longerich</surname><given-names>T</given-names></name><name><surname>Sansom</surname><given-names>OJ</given-names></name><name><surname>Benitah</surname><given-names>SA</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A complex secretory program orchestrated by the inflammasome controls paracrine senescence</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>978</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/ncb2784</pub-id><pub-id pub-id-type="pmid">23770676</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksenova</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Bhat</surname><given-names>P</given-names></name><name><surname>Esnault</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Iben</surname><given-names>J</given-names></name><name><surname>Kaufhold</surname><given-names>R</given-names></name><name><surname>Yau</surname><given-names>KC</given-names></name><name><surname>Echeverria</surname><given-names>C</given-names></name><name><surname>Fontoura</surname><given-names>B</given-names></name><name><surname>Arnaoutov</surname><given-names>A</given-names></name><name><surname>Dasso</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4577</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18266-2</pub-id><pub-id pub-id-type="pmid">32917881</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boumendil</surname><given-names>C</given-names></name><name><surname>Hari</surname><given-names>P</given-names></name><name><surname>Olsen</surname><given-names>KCF</given-names></name><name><surname>Acosta</surname><given-names>JC</given-names></name><name><surname>Bickmore</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nuclear pore density controls heterochromatin reorganization during senescence</article-title><source>Genes &amp; Development</source><volume>33</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1101/gad.321117.118</pub-id><pub-id pub-id-type="pmid">30692205</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braschi</surname><given-names>B</given-names></name><name><surname>Denny</surname><given-names>P</given-names></name><name><surname>Gray</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Seal</surname><given-names>R</given-names></name><name><surname>Tweedie</surname><given-names>S</given-names></name><name><surname>Yates</surname><given-names>B</given-names></name><name><surname>Bruford</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genenames.org: the HGNC and VGNC resources in 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D786</fpage><lpage>D792</lpage><pub-id pub-id-type="doi">10.1093/nar/gky930</pub-id><pub-id pub-id-type="pmid">30304474</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Giresi</surname><given-names>PG</given-names></name><name><surname>Zaba</surname><given-names>LC</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title><source>Nature Methods</source><volume>10</volume><fpage>1213</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id><pub-id pub-id-type="pmid">24097267</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Kirschner</surname><given-names>K</given-names></name><name><surname>Thuret</surname><given-names>JY</given-names></name><name><surname>Pope</surname><given-names>BD</given-names></name><name><surname>Ryba</surname><given-names>T</given-names></name><name><surname>Newman</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>K</given-names></name><name><surname>Samarajiwa</surname><given-names>SA</given-names></name><name><surname>Salama</surname><given-names>R</given-names></name><name><surname>Carroll</surname><given-names>T</given-names></name><name><surname>Stark</surname><given-names>R</given-names></name><name><surname>Janky</surname><given-names>R</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>L</given-names></name><name><surname>Chicas</surname><given-names>A</given-names></name><name><surname>Nũnez</surname><given-names>S</given-names></name><name><surname>Janknecht</surname><given-names>R</given-names></name><name><surname>Hayashi-Takanaka</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Marshall</surname><given-names>A</given-names></name><name><surname>Odom</surname><given-names>DT</given-names></name><name><surname>Babu</surname><given-names>MM</given-names></name><name><surname>Bazett-Jones</surname><given-names>DP</given-names></name><name><surname>Tavaré</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>PAW</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Gilbert</surname><given-names>DM</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation</article-title><source>Molecular Cell</source><volume>47</volume><fpage>203</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.06.010</pub-id><pub-id pub-id-type="pmid">22795131</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>Y</given-names></name><name><surname>Scuoppo</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Balgley</surname><given-names>B</given-names></name><name><surname>Bolden</surname><given-names>JE</given-names></name><name><surname>Premsrirut</surname><given-names>P</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Chicas</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name><name><surname>Kogan</surname><given-names>SC</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>2125</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1101/gad.17276711</pub-id><pub-id pub-id-type="pmid">21979375</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppé</surname><given-names>JP</given-names></name><name><surname>Desprez</surname><given-names>PY</given-names></name><name><surname>Krtolica</surname><given-names>A</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The senescence-associated secretory phenotype: the dark side of tumor suppression</article-title><source>Annual Review of Pathology</source><volume>5</volume><fpage>99</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-121808-102144</pub-id><pub-id pub-id-type="pmid">20078217</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corces</surname><given-names>MR</given-names></name><name><surname>Trevino</surname><given-names>AE</given-names></name><name><surname>Hamilton</surname><given-names>EG</given-names></name><name><surname>Greenside</surname><given-names>PG</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>NA</given-names></name><name><surname>Vesuna</surname><given-names>S</given-names></name><name><surname>Satpathy</surname><given-names>AT</given-names></name><name><surname>Rubin</surname><given-names>AJ</given-names></name><name><surname>Montine</surname><given-names>KS</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Kathiria</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>SW</given-names></name><name><surname>Mumbach</surname><given-names>MR</given-names></name><name><surname>Carter</surname><given-names>AC</given-names></name><name><surname>Kasowski</surname><given-names>M</given-names></name><name><surname>Orloff</surname><given-names>LA</given-names></name><name><surname>Risca</surname><given-names>VI</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name><name><surname>Montine</surname><given-names>TJ</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues</article-title><source>Nature Methods</source><volume>14</volume><fpage>959</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4396</pub-id><pub-id pub-id-type="pmid">28846090</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crasta</surname><given-names>K</given-names></name><name><surname>Ganem</surname><given-names>NJ</given-names></name><name><surname>Dagher</surname><given-names>R</given-names></name><name><surname>Lantermann</surname><given-names>AB</given-names></name><name><surname>Ivanova</surname><given-names>EV</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Nezi</surname><given-names>L</given-names></name><name><surname>Protopopov</surname><given-names>A</given-names></name><name><surname>Chowdhury</surname><given-names>D</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>DNA breaks and chromosome pulverization from errors in mitosis</article-title><source>Nature</source><volume>482</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nature10802</pub-id><pub-id pub-id-type="pmid">22258507</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cecco</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Petrashen</surname><given-names>AP</given-names></name><name><surname>Elias</surname><given-names>AE</given-names></name><name><surname>Skvir</surname><given-names>NJ</given-names></name><name><surname>Criscione</surname><given-names>SW</given-names></name><name><surname>Caligiana</surname><given-names>A</given-names></name><name><surname>Brocculi</surname><given-names>G</given-names></name><name><surname>Adney</surname><given-names>EM</given-names></name><name><surname>Boeke</surname><given-names>JD</given-names></name><name><surname>Le</surname><given-names>O</given-names></name><name><surname>Beauséjour</surname><given-names>C</given-names></name><name><surname>Ambati</surname><given-names>J</given-names></name><name><surname>Ambati</surname><given-names>K</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Seluanov</surname><given-names>A</given-names></name><name><surname>Gorbunova</surname><given-names>V</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Helfand</surname><given-names>SL</given-names></name><name><surname>Neretti</surname><given-names>N</given-names></name><name><surname>Sedivy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>L1 drives IFN in senescent cells and promotes age-associated inflammation</article-title><source>Nature</source><volume>566</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0784-9</pub-id><pub-id pub-id-type="pmid">30728521</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Donahue</surname><given-names>G</given-names></name><name><surname>Shimi</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>JA</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Ivanov</surname><given-names>A</given-names></name><name><surname>Capell</surname><given-names>BC</given-names></name><name><surname>Drake</surname><given-names>AM</given-names></name><name><surname>Shah</surname><given-names>PP</given-names></name><name><surname>Catanzaro</surname><given-names>JM</given-names></name><name><surname>Ricketts</surname><given-names>MD</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Adam</surname><given-names>SA</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Zong</surname><given-names>WX</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Autophagy mediates degradation of nuclear lamina</article-title><source>Nature</source><volume>527</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature15548</pub-id><pub-id pub-id-type="pmid">26524528</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Z</given-names></name><name><surname>Ghosh</surname><given-names>K</given-names></name><name><surname>Vizioli</surname><given-names>MG</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Sen</surname><given-names>P</given-names></name><name><surname>Wangensteen</surname><given-names>KJ</given-names></name><name><surname>Simithy</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Capell</surname><given-names>BC</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Kieckhaefer</surname><given-names>JE</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Shoshkes-Carmel</surname><given-names>M</given-names></name><name><surname>Tanim</surname><given-names>K</given-names></name><name><surname>Barber</surname><given-names>GN</given-names></name><name><surname>Seykora</surname><given-names>JT</given-names></name><name><surname>Millar</surname><given-names>SE</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Garcia</surname><given-names>BA</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cytoplasmic chromatin triggers inflammation in senescence and cancer</article-title><source>Nature</source><volume>550</volume><fpage>402</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1038/nature24050</pub-id><pub-id pub-id-type="pmid">28976970</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fišerová</surname><given-names>J</given-names></name><name><surname>Maninová</surname><given-names>M</given-names></name><name><surname>Sieger</surname><given-names>T</given-names></name><name><surname>Uhlířová</surname><given-names>J</given-names></name><name><surname>Šebestová</surname><given-names>L</given-names></name><name><surname>Efenberková</surname><given-names>M</given-names></name><name><surname>Čapek</surname><given-names>M</given-names></name><name><surname>Fišer</surname><given-names>K</given-names></name><name><surname>Hozák</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nuclear pore protein TPR associates with lamin B1 and affects nuclear lamina organization and nuclear pore distribution</article-title><source>Cellular and Molecular Life Sciences</source><volume>76</volume><fpage>2199</fpage><lpage>2216</lpage><pub-id pub-id-type="doi">10.1007/s00018-019-03037-0</pub-id><pub-id pub-id-type="pmid">30762072</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freund</surname><given-names>A</given-names></name><name><surname>Orjalo</surname><given-names>AV</given-names></name><name><surname>Desprez</surname><given-names>PY</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inflammatory networks during cellular senescence: causes and consequences</article-title><source>Trends in Molecular Medicine</source><volume>16</volume><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2010.03.003</pub-id><pub-id pub-id-type="pmid">20444648</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freund</surname><given-names>A</given-names></name><name><surname>Laberge</surname><given-names>RM</given-names></name><name><surname>Demaria</surname><given-names>M</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lamin B1 loss is a senescence-associated biomarker</article-title><source>Molecular Biology of the Cell</source><volume>23</volume><fpage>2066</fpage><lpage>2075</lpage><pub-id pub-id-type="doi">10.1091/mbc.E11-10-0884</pub-id><pub-id pub-id-type="pmid">22496421</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Cuevas</surname><given-names>VC</given-names></name><name><surname>Seelbinder</surname><given-names>B</given-names></name><name><surname>Neu</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Image-based elastography of heterochromatin and euchromatin domains in the deforming cell nucleus</article-title><source>Small</source><volume>17</volume><elocation-id>e2006109</elocation-id><pub-id pub-id-type="doi">10.1002/smll.202006109</pub-id><pub-id pub-id-type="pmid">33448065</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glück</surname><given-names>S</given-names></name><name><surname>Guey</surname><given-names>B</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Wolter</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>TW</given-names></name><name><surname>Schmacke</surname><given-names>NA</given-names></name><name><surname>Bridgeman</surname><given-names>A</given-names></name><name><surname>Rehwinkel</surname><given-names>J</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Ablasser</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>1061</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1038/ncb3586</pub-id><pub-id pub-id-type="pmid">28759028</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guelen</surname><given-names>L</given-names></name><name><surname>Pagie</surname><given-names>L</given-names></name><name><surname>Brasset</surname><given-names>E</given-names></name><name><surname>Meuleman</surname><given-names>W</given-names></name><name><surname>Faza</surname><given-names>MB</given-names></name><name><surname>Talhout</surname><given-names>W</given-names></name><name><surname>Eussen</surname><given-names>BH</given-names></name><name><surname>de Klein</surname><given-names>A</given-names></name><name><surname>Wessels</surname><given-names>L</given-names></name><name><surname>de Laat</surname><given-names>W</given-names></name><name><surname>van Steensel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions</article-title><source>Nature</source><volume>453</volume><fpage>948</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1038/nature06947</pub-id><pub-id pub-id-type="pmid">18463634</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hase</surname><given-names>ME</given-names></name><name><surname>Cordes</surname><given-names>VC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex</article-title><source>Molecular Biology of the Cell</source><volume>14</volume><fpage>1923</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1091/mbc.e02-09-0620</pub-id><pub-id pub-id-type="pmid">12802065</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatch</surname><given-names>EM</given-names></name><name><surname>Fischer</surname><given-names>AH</given-names></name><name><surname>Deerinck</surname><given-names>TJ</given-names></name><name><surname>Hetzer</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Catastrophic nuclear envelope collapse in cancer cell micronuclei</article-title><source>Cell</source><volume>154</volume><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.007</pub-id><pub-id pub-id-type="pmid">23827674</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>MS</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NF-κB, the first quarter-century: remarkable progress and outstanding questions</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>203</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1101/gad.183434.111</pub-id><pub-id pub-id-type="pmid">22302935</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Spann</surname><given-names>N</given-names></name><name><surname>Bertolino</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Laslo</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>JX</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoare</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>TW</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Matheson</surname><given-names>NJ</given-names></name><name><surname>Patten</surname><given-names>DA</given-names></name><name><surname>Shetty</surname><given-names>S</given-names></name><name><surname>Parry</surname><given-names>AJ</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Salama</surname><given-names>R</given-names></name><name><surname>Antrobus</surname><given-names>R</given-names></name><name><surname>Tomimatsu</surname><given-names>K</given-names></name><name><surname>Howat</surname><given-names>W</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>NOTCH1 mediates a switch between two distinct secretomes during senescence</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>979</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1038/ncb3397</pub-id><pub-id pub-id-type="pmid">27525720</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarra</surname><given-names>A</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Cool</surname><given-names>J</given-names></name><name><surname>Hetzer</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nucleoporin-mediated regulation of cell identity genes</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>2253</fpage><lpage>2258</lpage><pub-id pub-id-type="doi">10.1101/gad.287417.116</pub-id><pub-id pub-id-type="pmid">27807035</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>A</given-names></name><name><surname>Pawlikowski</surname><given-names>J</given-names></name><name><surname>Manoharan</surname><given-names>I</given-names></name><name><surname>van Tuyn</surname><given-names>J</given-names></name><name><surname>Nelson</surname><given-names>DM</given-names></name><name><surname>Rai</surname><given-names>TS</given-names></name><name><surname>Shah</surname><given-names>PP</given-names></name><name><surname>Hewitt</surname><given-names>G</given-names></name><name><surname>Korolchuk</surname><given-names>VI</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lysosome-mediated processing of chromatin in senescence</article-title><source>The Journal of Cell Biology</source><volume>202</volume><fpage>129</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1083/jcb.201212110</pub-id><pub-id pub-id-type="pmid">23816621</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Tam</surname><given-names>OH</given-names></name><name><surname>Paniagua</surname><given-names>E</given-names></name><name><surname>Hammell</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets</article-title><source>Bioinformatics</source><volume>31</volume><fpage>3593</fpage><lpage>3599</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv422</pub-id><pub-id pub-id-type="pmid">26206304</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kale</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Stolzing</surname><given-names>A</given-names></name><name><surname>Desprez</surname><given-names>PY</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Role of immune cells in the removal of deleterious senescent cells</article-title><source>Immunity &amp; Ageing</source><volume>17</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s12979-020-00187-9</pub-id><pub-id pub-id-type="pmid">32518575</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Paggi</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>907</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id><pub-id pub-id-type="pmid">31375807</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krull</surname><given-names>S</given-names></name><name><surname>Dörries</surname><given-names>J</given-names></name><name><surname>Boysen</surname><given-names>B</given-names></name><name><surname>Reidenbach</surname><given-names>S</given-names></name><name><surname>Magnius</surname><given-names>L</given-names></name><name><surname>Norder</surname><given-names>H</given-names></name><name><surname>Thyberg</surname><given-names>J</given-names></name><name><surname>Cordes</surname><given-names>VC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>1659</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.54</pub-id><pub-id pub-id-type="pmid">20407419</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuilman</surname><given-names>T</given-names></name><name><surname>Michaloglou</surname><given-names>C</given-names></name><name><surname>Vredeveld</surname><given-names>LCW</given-names></name><name><surname>Douma</surname><given-names>S</given-names></name><name><surname>van Doorn</surname><given-names>R</given-names></name><name><surname>Desmet</surname><given-names>CJ</given-names></name><name><surname>Aarden</surname><given-names>LA</given-names></name><name><surname>Mooi</surname><given-names>WJ</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network</article-title><source>Cell</source><volume>133</volume><fpage>1019</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.03.039</pub-id><pub-id pub-id-type="pmid">18555778</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>ES</given-names></name><name><surname>Wolf</surname><given-names>EJ</given-names></name><name><surname>Ihn</surname><given-names>SSJ</given-names></name><name><surname>Smith</surname><given-names>HW</given-names></name><name><surname>Emili</surname><given-names>A</given-names></name><name><surname>Palazzo</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TPR is required for the efficient nuclear export of mRNAs and lncRNAs from short and intron-poor genes</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>11645</fpage><lpage>11663</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa919</pub-id><pub-id pub-id-type="pmid">33091126</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>M</given-names></name><name><surname>Mannino</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Renda</surname><given-names>F</given-names></name><name><surname>Khodjakov</surname><given-names>A</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear envelope assembly defects link mitotic errors to chromothripsis</article-title><source>Nature</source><volume>561</volume><fpage>551</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0534-z</pub-id><pub-id pub-id-type="pmid">30232450</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>G</given-names></name><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Ji</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Esteban</surname><given-names>CR</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>YE</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Belmonte</surname><given-names>JCI</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Resurrection of endogenous retroviruses during aging reinforces senescence</article-title><source>Cell</source><volume>186</volume><fpage>287</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.12.017</pub-id><pub-id pub-id-type="pmid">36610399</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mammel</surname><given-names>AE</given-names></name><name><surname>Huang</surname><given-names>HZ</given-names></name><name><surname>Gunn</surname><given-names>AL</given-names></name><name><surname>Choo</surname><given-names>E</given-names></name><name><surname>Hatch</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Chromosome length and gene density contribute to micronuclear membrane stability</article-title><source>Life Science Alliance</source><volume>5</volume><elocation-id>e202101210</elocation-id><pub-id pub-id-type="doi">10.26508/lsa.202101210</pub-id><pub-id pub-id-type="pmid">34789512</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet.Journal</source><volume>17</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Zamudio</surname><given-names>RI</given-names></name><name><surname>Roux</surname><given-names>PF</given-names></name><name><surname>de Freitas</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>L</given-names></name><name><surname>Doré</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Belenki</surname><given-names>D</given-names></name><name><surname>Milanovic</surname><given-names>M</given-names></name><name><surname>Herbig</surname><given-names>U</given-names></name><name><surname>Schmitt</surname><given-names>CA</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name><name><surname>Bischof</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>AP-1 imprints a reversible transcriptional programme of senescent cells</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>842</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0529-5</pub-id><pub-id pub-id-type="pmid">32514071</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>CY</given-names></name><name><surname>Bristor</surname><given-names>D</given-names></name><name><surname>Hiller</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>SL</given-names></name><name><surname>Schaar</surname><given-names>BT</given-names></name><name><surname>Lowe</surname><given-names>CB</given-names></name><name><surname>Wenger</surname><given-names>AM</given-names></name><name><surname>Bejerano</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/nbt.1630</pub-id><pub-id pub-id-type="pmid">20436461</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KN</given-names></name><name><surname>Victorelli</surname><given-names>SG</given-names></name><name><surname>Salmonowicz</surname><given-names>H</given-names></name><name><surname>Dasgupta</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cytoplasmic DNA: sources, sensing, and role in aging and disease</article-title><source>Cell</source><volume>184</volume><fpage>5506</fpage><lpage>5526</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.09.034</pub-id><pub-id pub-id-type="pmid">34715021</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Nũnez</surname><given-names>S</given-names></name><name><surname>Heard</surname><given-names>E</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>AW</given-names></name><name><surname>Hearn</surname><given-names>SA</given-names></name><name><surname>Spector</surname><given-names>DL</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence</article-title><source>Cell</source><volume>113</volume><fpage>703</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00401-x</pub-id><pub-id pub-id-type="pmid">12809602</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Krizhanovsky</surname><given-names>V</given-names></name><name><surname>Nuñez</surname><given-names>S</given-names></name><name><surname>Chicas</surname><given-names>A</given-names></name><name><surname>Hearn</surname><given-names>SA</given-names></name><name><surname>Myers</surname><given-names>MP</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation</article-title><source>Cell</source><volume>126</volume><fpage>503</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.05.052</pub-id><pub-id pub-id-type="pmid">16901784</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nassar</surname><given-names>LR</given-names></name><name><surname>Barber</surname><given-names>GP</given-names></name><name><surname>Benet-Pagès</surname><given-names>A</given-names></name><name><surname>Casper</surname><given-names>J</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>JN</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Lee</surname><given-names>BT</given-names></name><name><surname>Lee</surname><given-names>CM</given-names></name><name><surname>Muthuraman</surname><given-names>P</given-names></name><name><surname>Nguy</surname><given-names>B</given-names></name><name><surname>Pereira</surname><given-names>T</given-names></name><name><surname>Nejad</surname><given-names>P</given-names></name><name><surname>Perez</surname><given-names>G</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Schmelter</surname><given-names>D</given-names></name><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Wick</surname><given-names>BD</given-names></name><name><surname>Zweig</surname><given-names>AS</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The UCSC Genome Browser database: 2023 update</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>D1188</fpage><lpage>D1195</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1072</pub-id><pub-id pub-id-type="pmid">36420891</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olan</surname><given-names>I</given-names></name><name><surname>Ando-Kuri</surname><given-names>M</given-names></name><name><surname>Parry</surname><given-names>AJ</given-names></name><name><surname>Handa</surname><given-names>T</given-names></name><name><surname>Schoenfelder</surname><given-names>S</given-names></name><name><surname>Fraser</surname><given-names>P</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>HMGA1 orchestrates chromatin compartmentalization and sequesters genes into 3D networks coordinating senescence heterogeneity</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>6891</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-51153-8</pub-id><pub-id pub-id-type="pmid">39134516</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orjalo</surname><given-names>AV</given-names></name><name><surname>Bhaumik</surname><given-names>D</given-names></name><name><surname>Gengler</surname><given-names>BK</given-names></name><name><surname>Scott</surname><given-names>GK</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network</article-title><source>PNAS</source><volume>106</volume><fpage>17031</fpage><lpage>17036</lpage><pub-id pub-id-type="doi">10.1073/pnas.0905299106</pub-id><pub-id pub-id-type="pmid">19805069</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parry</surname><given-names>AJ</given-names></name><name><surname>Hoare</surname><given-names>M</given-names></name><name><surname>Bihary</surname><given-names>D</given-names></name><name><surname>Hänsel-Hertsch</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Tomimatsu</surname><given-names>K</given-names></name><name><surname>Mannion</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>D’Santos</surname><given-names>P</given-names></name><name><surname>Russell</surname><given-names>IA</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Samarajiwa</surname><given-names>SA</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1840</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04283-9</pub-id><pub-id pub-id-type="pmid">29743479</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual-Garcia</surname><given-names>P</given-names></name><name><surname>Debo</surname><given-names>B</given-names></name><name><surname>Aleman</surname><given-names>JR</given-names></name><name><surname>Talamas</surname><given-names>JA</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>NH</given-names></name><name><surname>Won</surname><given-names>KJ</given-names></name><name><surname>Capelson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metazoan nuclear pores provide a scaffold for poised genes and mediate induced enhancer-promoter contacts</article-title><source>Molecular Cell</source><volume>66</volume><fpage>63</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.020</pub-id><pub-id pub-id-type="pmid">28366641</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>F</given-names></name><name><surname>Ryan</surname><given-names>DP</given-names></name><name><surname>Grüning</surname><given-names>B</given-names></name><name><surname>Bhardwaj</surname><given-names>V</given-names></name><name><surname>Kilpert</surname><given-names>F</given-names></name><name><surname>Richter</surname><given-names>AS</given-names></name><name><surname>Heyne</surname><given-names>S</given-names></name><name><surname>Dündar</surname><given-names>F</given-names></name><name><surname>Manke</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>deepTools2: a next generation web server for deep-sequencing data analysis</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W160</fpage><lpage>W165</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw257</pub-id><pub-id pub-id-type="pmid">27079975</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Research</source><volume>43</volume><elocation-id>e47</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruhland</surname><given-names>MK</given-names></name><name><surname>Loza</surname><given-names>AJ</given-names></name><name><surname>Capietto</surname><given-names>AH</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Knolhoff</surname><given-names>BL</given-names></name><name><surname>Flanagan</surname><given-names>KC</given-names></name><name><surname>Belt</surname><given-names>BA</given-names></name><name><surname>Alspach</surname><given-names>E</given-names></name><name><surname>Leahy</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Schaffer</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>JR</given-names></name><name><surname>Longmore</surname><given-names>G</given-names></name><name><surname>Faccio</surname><given-names>R</given-names></name><name><surname>DeNardo</surname><given-names>DG</given-names></name><name><surname>Stewart</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11762</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11762</pub-id><pub-id pub-id-type="pmid">27272654</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadaie</surname><given-names>M</given-names></name><name><surname>Salama</surname><given-names>R</given-names></name><name><surname>Carroll</surname><given-names>T</given-names></name><name><surname>Tomimatsu</surname><given-names>K</given-names></name><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>ARJ</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Pérez-Mancera</surname><given-names>PA</given-names></name><name><surname>Bennett</surname><given-names>DC</given-names></name><name><surname>Chong</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1800</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.1101/gad.217281.113</pub-id><pub-id pub-id-type="pmid">23964094</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Miyoshi</surname><given-names>H</given-names></name><name><surname>Sugita</surname><given-names>T</given-names></name><name><surname>Toriumi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>30353</fpage><lpage>30356</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.43.30353</pub-id><pub-id pub-id-type="pmid">10521409</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimi</surname><given-names>T</given-names></name><name><surname>Butin-Israeli</surname><given-names>V</given-names></name><name><surname>Adam</surname><given-names>SA</given-names></name><name><surname>Hamanaka</surname><given-names>RB</given-names></name><name><surname>Goldman</surname><given-names>AE</given-names></name><name><surname>Lucas</surname><given-names>CA</given-names></name><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Kosak</surname><given-names>ST</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The role of nuclear lamin B1 in cell proliferation and senescence</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>2579</fpage><lpage>2593</lpage><pub-id pub-id-type="doi">10.1101/gad.179515.111</pub-id><pub-id pub-id-type="pmid">22155925</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>C</given-names></name><name><surname>Sankaran</surname><given-names>B</given-names></name><name><surname>Chaton</surname><given-names>CT</given-names></name><name><surname>Herr</surname><given-names>AB</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural insights into the functions of TBK1 in innate antimicrobial immunity</article-title><source>Structure</source><volume>21</volume><fpage>1137</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1016/j.str.2013.04.025</pub-id><pub-id pub-id-type="pmid">23746807</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>AD</given-names></name><name><surname>Liu</surname><given-names>PZ</given-names></name><name><surname>Banigan</surname><given-names>EJ</given-names></name><name><surname>Almassalha</surname><given-names>LM</given-names></name><name><surname>Backman</surname><given-names>V</given-names></name><name><surname>Adam</surname><given-names>SA</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name><name><surname>Marko</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chromatin histone modifications and rigidity affect nuclear morphology independent of lamins</article-title><source>Molecular Biology of the Cell</source><volume>29</volume><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1091/mbc.E17-06-0410</pub-id><pub-id pub-id-type="pmid">29142071</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stirling</surname><given-names>DR</given-names></name><name><surname>Swain-Bowden</surname><given-names>MJ</given-names></name><name><surname>Lucas</surname><given-names>AM</given-names></name><name><surname>Carpenter</surname><given-names>AE</given-names></name><name><surname>Cimini</surname><given-names>BA</given-names></name><name><surname>Goodman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>CellProfiler 4: improvements in speed, utility and usability</article-title><source>BMC Bioinformatics</source><volume>22</volume><elocation-id>433</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-021-04344-9</pub-id><pub-id pub-id-type="pmid">34507520</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasdemir</surname><given-names>N</given-names></name><name><surname>Banito</surname><given-names>A</given-names></name><name><surname>Roe</surname><given-names>JS</given-names></name><name><surname>Alonso-Curbelo</surname><given-names>D</given-names></name><name><surname>Camiolo</surname><given-names>M</given-names></name><name><surname>Tschaharganeh</surname><given-names>DF</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Aksoy</surname><given-names>O</given-names></name><name><surname>Bolden</surname><given-names>JE</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Fennell</surname><given-names>M</given-names></name><name><surname>Thapar</surname><given-names>V</given-names></name><name><surname>Chicas</surname><given-names>A</given-names></name><name><surname>Vakoc</surname><given-names>CR</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance</article-title><source>Cancer Discovery</source><volume>6</volume><fpage>612</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-16-0217</pub-id><pub-id pub-id-type="pmid">27099234</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unterholzner</surname><given-names>L</given-names></name><name><surname>Dunphy</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>cGAS-independent STING activation in response to DNA damage</article-title><source>Molecular &amp; Cellular Oncology</source><volume>6</volume><elocation-id>1558682</elocation-id><pub-id pub-id-type="doi">10.1080/23723556.2018.1558682</pub-id><pub-id pub-id-type="pmid">31211228</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Van der Auwera</surname><given-names>GA</given-names></name><name><surname>O’Connor</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>Genomics in the Cloud: Using Docker, GATK, and WDL in Terra</source><publisher-name>O’Reilly Media</publisher-name></element-citation></ref><ref id="bib66"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-name>Springer-Verlag</publisher-name></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>W</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Miething</surname><given-names>C</given-names></name><name><surname>Dickins</surname><given-names>RA</given-names></name><name><surname>Hernando</surname><given-names>E</given-names></name><name><surname>Krizhanovsky</surname><given-names>V</given-names></name><name><surname>Cordon-Cardo</surname><given-names>C</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas</article-title><source>Nature</source><volume>445</volume><fpage>656</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/nature05529</pub-id><pub-id pub-id-type="pmid">17251933</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>cGAS is essential for cellular senescence</article-title><source>PNAS</source><volume>114</volume><fpage>E4612</fpage><lpage>E4620</lpage><pub-id pub-id-type="doi">10.1073/pnas.1705499114</pub-id><pub-id pub-id-type="pmid">28533362</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>ARJ</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Ferreira</surname><given-names>M</given-names></name><name><surname>Kirschner</surname><given-names>K</given-names></name><name><surname>Sadaie</surname><given-names>M</given-names></name><name><surname>Darot</surname><given-names>JFJ</given-names></name><name><surname>Tavaré</surname><given-names>S</given-names></name><name><surname>Arakawa</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Autophagy mediates the mitotic senescence transition</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>798</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1101/gad.519709</pub-id><pub-id pub-id-type="pmid">19279323</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Shirley Liu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Model-based Analysis of ChIP-Seq (MACS)</article-title><source>Genome Biology</source><volume>9</volume><elocation-id>R137</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">IMR90 STOP cells</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Acosta et al., 2013</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Generated in the J-C Acosta lab</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">IMR90 RAS cells</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Acosta et al., 2013</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Generated in the J-C Acosta lab</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-β-actin−HRP (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A3854</td><td align="left" valign="bottom">WB (1:80000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GAPDH (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab125247, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB2011129118">AB 11129118</ext-link></td><td align="left" valign="bottom">WB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho-Histone H2AX <break/>(Ser139) (mouse monoclonal)</td><td align="left" valign="bottom">Merck</td><td align="char" char="ndash" valign="bottom">05–636</td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-H3K27me2/me3 (mouse monoclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="left" valign="bottom">#39536 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2793247">AB_2793247</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-H3K9me3 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab8898 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_306848">AB_306848</ext-link></td><td align="left" valign="bottom">IF (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-IKKα (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#2682 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_331626">AB_331626</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti phospho-IKKα/β <break/>(Ser176/180) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#2697 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2079382">AB_2079382</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-NF-κB p65 (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-8008 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_628017">AB_628017</ext-link></td><td align="left" valign="bottom">WB (1:1000), IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-NF-κB p65 (rabbit <break/>recombinant monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#8242 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10859369">AB_10859369</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho- NF-κB p65 <break/>(Ser536) (rabbit recombinant <break/>monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#3033 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_331284">AB_331284</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-POM121 (rabbit polyclonal)</td><td align="left" valign="bottom">Genetex</td><td align="left" valign="bottom">GTX102128 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10732546">AB_10732546</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-STING (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#13647 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2732796">AB_2732796</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phosphoTBK1 (Ser172) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#5483 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10693472">AB_10693472</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TPR (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab84516</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-vinculin (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab91459 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2050446">AB_2050446</ext-link></td><td align="left" valign="bottom">WB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit IgG (H+L) secondary, <break/>Alexa Fluor 488 (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A11034</td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse IgG (H+L) secondary, <break/>Alexa Fluor 568 (donkey polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A10037</td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit IgG, HRP-linked (goat polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#7074 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2099233">AB_2099233</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse IgG, HRP-linked (horse polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#7076 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_330924">AB_330924</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">siCTRL</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">D-001810-10-59</td><td align="left" valign="bottom">ON-TARGETplus siRNA pool</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">siTPR</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">L-010548–00</td><td align="left" valign="bottom">ON-TARGETplus siRNA pool</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">siHMGA1</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">L-004597–00</td><td align="left" valign="bottom">ON-TARGETplus siRNA pool</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">STING1_Fwd</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref></td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">ATATCTGCGGCTGATCCTGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">STING1_Rev</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref></td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TTGTAAGTTCGAATCCGGGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH_Fwd</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref></td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">CAGCCTCAAGATCATCAGCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH_Rev</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Dou et al., 2017</xref></td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TGTGGTCATGAGTCCTTCCA</named-content></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pierce BCA protein <break/>analysis kit</td><td align="left" valign="bottom">Thermo Fisher</td><td align="char" char="." valign="bottom">23225</td><td align="left" valign="bottom">Methods: Immunoblotting</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SuperSignal West Femto <break/>maximum sensitivity <break/>substrate kit</td><td align="left" valign="bottom">Thermo Fisher</td><td align="char" char="." valign="bottom">10095983</td><td align="left" valign="bottom">Methods: Immunoblotting</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">2’3’-cGAMP ELISA kit</td><td align="left" valign="bottom">Cayman Chemical</td><td align="char" char="." valign="bottom">501700</td><td align="left" valign="bottom">Methods: 2’3’-cGAMP ELISA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy mini kit</td><td align="left" valign="bottom">Qiagen</td><td align="char" char="." valign="bottom">74104</td><td align="left" valign="bottom">Methods: RT-qPCR and RNA <break/>seq­­ library preparation</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Ultra II <break/>Directional RNA library <break/>prep kit</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7760</td><td align="left" valign="bottom">Methods: RNA seq­­ <break/>library preparation</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Poly(A) mRNA <break/>Magnetic Isolation Module</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7490</td><td align="left" valign="bottom">Methods: RNA seq­­ <break/>library preparation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4-hydroxytamoxifen</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">H7904</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">H3K27ac ChIP-seq</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Parry et al., 2018</xref></td><td align="left" valign="bottom">NCBI GEO: GSE103590</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">ATAC-seq</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">NCBI GEO: GSE264390</td><td align="left" valign="bottom">See Methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">RNA-seq</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">NCBI GEO: GSE264387</td><td align="left" valign="bottom">See Methods</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellProfiler</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Stirling et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_007358">SCR_007358</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Micromanager</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://micromanager.org">https://micromanager.org</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Version 1.4</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FastQC</td><td align="left" valign="bottom"/><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014583">SCR_014583</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cutadapt</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Martin, 2011</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_011841">SCR_011841</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">bowtie2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Langmead and Salzberg, 2012</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016368">SCR_016368</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MACS2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib71">Zhang et al., 2008</xref>;<break/><break/><ext-link ext-link-type="uri" xlink:href="https://pypi.org/project/MACS2/">https://pypi.org/project/MACS2/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HOMER</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Heinz et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_010881">SCR_010881</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">edgeR</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib54">Robinson et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_012802">SCR_012802</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">limma</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Ritchie et al., 2015</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_010943">SCR_010943</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">deepTools</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib52">Ramírez et al., 2016</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016366">SCR_016366</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GREAT</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">McLean et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_005807">SCR_005807</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HISAT2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Kim et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015530">SCR_015530</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GATK</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Van der Auwera <break/>and O’Connor, 2020</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015530">SCR_015530</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">subread</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Liao et al., 2014</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_009803">SCR_009803</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DeSeq2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Love et al., 2014</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015687">SCR_015687</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterProfiler</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Wu et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016884">SCR_016884</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggplot2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib66">Wickham, 2016</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014601">SCR_014601</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">TEtranscripts</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Jin et al., 2015</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_023208">SCR_023208</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101702.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This report provides significant strides in advancing our understanding of how senescence pathway mediated chromatin defects affects genome instability as we age. Their innovative approach, combined with thorough experimental work, provides compelling evidence linking heterochromatin reorganization to the SAHF-CCF-SASP axis. This important work will be of particular interest to the aging, genome instability and cancer fields.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101702.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p><p>Thank you for submitting your article &quot;TPR is required for cytoplasmic chromatin fragment formation during senescence&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers at Review Commons, and the evaluation at <italic>eLife</italic> has been overseen by Yamini Dalal as the Senior Editor.</p><p>Based on the previous reviews and the revisions, the manuscript has been improved sufficiently for two out of three reviewers. There are some remaining issues that need to be addressed before we can proceed to publication -- one reviewer noted major files were missing in the merged version they reviewed, they ask you to ensure the files are present. The third reviewer is still unconvinced on some key points – I suggest including a rebuttal that specifically addresses those points, and textual clarification that will assist readers of this work.</p><p><italic>Reviewer #1:</italic></p><p>The authors have addressed all of my questions and have conducted additional experiments. However, the manuscript is not yet ready for acceptance. I was unable to locate the tables and supplementary files mentioned, which may have been omitted by mistake. Please ensure these are uploaded. I expect that Table 2, as per my recommendation, is included as claimed in the text. If so, after editorial screening, the manuscript can be accepted. The authors have made significant strides in advancing our understanding of the SAHF-CCF-SASP axis. Their innovative approach, combined with thorough experimental work, provides compelling evidence linking heterochromatin reorganization to CCF formation.</p><p><italic>Reviewer #3:</italic></p><p>In the revised manuscript, the authors claimed that TPR is required for CCF formation during senescence. However, this conclusion is unsupported by the new data. In fact, the results collectively suggest an alternative pathway of how TPR regulates the SASP. As articulated below, there are serious major issues that preclude publication of this manuscript at <italic>eLife</italic>.</p><p>1. The study uses a single cell strain IMR90 undergoing a single form of senescence, induced by activated Ras. CCF in this system is less than 6%, arguing against a central role for CCF in mediating the NFkB pathway. Additional systems with more robust CCF must be included.</p><p>2. The authors presented new data showing that cGAMP is induced in OIS. However, disruption of TPR had no effect on cGAMP level. This result suggests that cGAS is not affected by TPR, again arguing against the central conclusion that CCF is involved.</p><p>3. The results that TPR affects STING expression level suggest that TPR does not go through CCF to regulate NFkB. First, CCF is not known to regulate STING expression level. Second, TPR may affect mRNA processing to regulate STING expression, which again can be independent of CCF. This alternative interpretation makes more sense to this reviewer, as I do not see how CCF is a central player regulated by TPR.</p><p>4. The authors suggest that the formation of SAHF is linked to CCF. However, BJ cells undergoing IR and replicative senescence show prominent CCF without SAHF. Again, without testing the generalizability of the finding, the authors overinterpreted the results using a single system.</p><p>All in all, the central conclusion of CCF is unsupported by the data. However, I do believe the NFkB and STING data. I suggest that the authors remove CCF data and focus on how TPR regulates STING expression. To establish TPR goes through STING to affect NFkB, I suggest overexpressing STING in TPR knockdown senescent cells, and check if NFkB and SASP can be restored.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.101702.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>General Statements</p><p>We thank the reviewers for taking the time to carefully review our preprint, to highlight the clarity of our experimental data, and to provide their constructive comments. We plan to address these comments as listed below.</p><disp-quote content-type="editor-comment"><p>Reviewer #1</p><p>i) &quot;Enhancers dependent on TPR during senescence are enriched for binding sites of inflammatory transcription factors&quot;.</p><p>Proximity to genes does not confirm an enhancer role for that gene, although Tasdemir et al., 2016 suggested this. At that time, HI-C and Hi-CHiP techniques were not well-established. Nowadays, without combining HI-C and H3K27ac ChIP, Hi-ChIP alone cannot definitively identify actual enhancer regions. If we repeatedly use the Tasdemir et al., 2016 map, we risk incorrect mapping of enhancers of SASP. The authors should either use other public Hi-C databases to map the enhancer of SASP or temper their conclusions about enhancers. Otherwise, this could set a precedent for the SASP enhancer region that might not be entirely accurate.</p><p>The enhancer mapping for SASP is outdated, as advancements in Hi-C have significantly developed this area. Therefore, the claimed enhancers of SASP may not be accurate.</p></disp-quote><p>We agree with the reviewer that enhancers are not easy to define, or to pair with their target gene(s). Indeed, we would argue that even combined HI-C and H3K27ac does not define enhancers or enhancer-gene pairs and that the gold-standard evidence for an enhancer is genetics – does its deletion/mutation abrogate gene activation. We would also point out that we did not actually use the Tasdemir data to call enhancers. In response to the reviewer’s comment, we will temper our terminology and now refer to our inter-and intra-genic ATAC-seq peaks only as “putative enhancers”.</p><p>ii) “<italic>Many of these include putative enhancers located close to key SASP genes, such as IL1B and IL8 (Figure 1D</italic>).”</p><disp-quote content-type="editor-comment"><p>I have the same concern as mentioned above (i). However, I am interested in knowing the other key SASP genes where DNA is accessible near the genes. A supplementary table listing key SASP genes along with their distances to the TSS and affected by TPR knock-down would be helpful.</p></disp-quote><p>We thank the reviewer for this suggestion. In the revised manuscript, we now provide a table (Table 2) listing the TPR dependent, senescent specific ATAC-seq peaks that are close to genes associated with the ‘positive regulation of inflammatory response’, ‘cytokine activity’ and ‘cytokine receptor binding’ gene ontology terms which were significant in the GREAT analysis, and which includes many SASP genes. This Table also gives the distances (bp) of these regions from the associated gene TSS.</p><disp-quote content-type="editor-comment"><p>iii) &quot;As we previously reported, knockdown of TPR (siTPR) in RAS cells blocks SAHF formation, but it also results in reduced nuclear localisation (decreased nucleocytoplasmic ratio) of NF-κB, consistent with decreased NF-κB activation (Figure 2A and B, Figure S2A).&quot;</p><p>TPR is required for CCF, SASP, and SAHF. The relationship between CCF and SASP is well established, but the relationship between SAHF and CCF/SASP remains elusive. Both SAHF and CCF are enriched with heterochromatin markers, suggesting that CCF might originate from SAHF. However, this has not been confirmed. Do the authors think that SAHF is a prerequisite for CCF in the OIS model, or is it an independent event?</p></disp-quote><p>We agree with the reviewer that CCFs likely originate from SAHF. Whilst we cannot definitively prove this in our ER-Ras OIS model, in the revised manuscript we intend to further investigate the relationship between SAHF and CCF by knocking down HMGA1 during RAS-induced senescence. Like TPR, HMGA1 depletion is known to lead to loss of SAHF (Narita et al., Cell, 2006) but, unlike TPR, HMGA1 is a chromatin protein enriched on heterochromatin itself. We will assess whether loss of HMGA1 also abrogates CCF formation<bold>.</bold></p><disp-quote content-type="editor-comment"><p>iv) The authors suggested that &quot;it is plausible that the decrease in CCFs produced during the early phases of OIS upon TPR knockdown may be caused by an increase in the stability of the nuclear periphery due to the heterochromatin that remains there when SAHF are not formed.&quot; I do not completely agree with this explanation because CCF starts forming at day 3-4 but culminates at later time points. According to Figure 5A, only 5-6% of cells are positive for CCFs on day 5. What happens on day 8? By day 8, the percentage of CCF-positive cells could be 20-25%, or the number of CCFs per cell might be 0.2-0.3. If TPR is not required for CCF formation at this stage, then linking CCF to SASP at day 8 becomes critical. This suggests that another mechanism might be driving SASP expression and that TPR could be regulating downstream signaling of CCF. It is possible that changes in nuclear pore density affect the localization of cGAS from the nucleus to the cytoplasm.</p></disp-quote><p>In our hands, and using the IMR90 ER-RAS system, CCF formation decreases later in senescence (d8 - only 2% of cells) hence our focus on early timepoints after oncogenic RAS activation. At later timepoints, cGAS activation is also mediated by retrotransposons (de Cecco et al., Nature, 2019; Liu et al., Cell, 2023), as well as leakage of mitochondrial DNA (Victorelli et al., Nature, 2023; Chen et al., Nat. Comms, 2024), and so it is difficult to disentangle the net contribution of these three inputs at the later timepoints<bold>.</bold></p><disp-quote content-type="editor-comment"><p>v) Additionally, the authors did not address what happens in the later stages of CCF formation in the absence of TPR. If TPR is not required for CCF formation at later stages, it fails to explain the downstream processes at these time points adequately. This suggests that TPR may also have another mechanism of SASP regulation independent of CCF formation.</p></disp-quote><p>In our cellular system CCFs precede the SASP – CCFs are already present at day 3 but SASP factors are not secreted until day 5. However, CCFs are not necessarily required for maintenance of the SASP. Once initiated the SASP is maintained by cytokine feedback loops.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>1. The claim that TPR knockdown does not affect NFkappaB nuclear translocation indeed stands, but it would be nice if the authors also compared data across conditions in Figure 2F, i.e. siCTRL+Ras CM versus siTPR+Ras CM in RAS cells and provided a p-value as it seems to me that there is some dampening of translocation intensity, which is clearly not the case for STOP cells. The authors focus on this for d3 and d5, but it seems to be also the case for later time points.</p></disp-quote><p>As basal NF-κB translocation is lower in RAS cells on TPR knockdown, we would expect a dampening in NF-κB translocation between siCTRL+RAS CM and siTPR+Ras CM regardless of whether there is a transportation defect. In response to the reviewer’s comment we have added a table with median nuclear:cytoplasmic NF-κB ratios and 95% confidence intervals for the data in Fig2B and F and for the NF-κB analyses in Figure 3, and for the corresponding biological replicates in supplementary figures. These tables are now Figure 2 -source data 1 and Figure 3 – source data 1.</p><disp-quote content-type="editor-comment"><p>2. Also, a comment based on literature or from the authors previous work on TPR, on the extent to which the structural integrity of the nuclear basket is at all affected upon TPR depletion would be helpful for data interpretation.</p></disp-quote><p>In the revised manuscript we will refer to the literature showing that TPR is the final component added to the nuclear pore and that its absence does not affect localisation of NUP153 to the nuclear basket (Hase and Cordes., Mol. Biol. Cell 2003; Aksenova et al., Nat Comms, 2020).</p><disp-quote content-type="editor-comment"><p>3. Magnification of representative cells per each condition in Figure 2E would be welcome.</p></disp-quote><p>We have included the requested magnifications in a revised figure 2E.</p><disp-quote content-type="editor-comment"><p>4. Regarding the data in Figures3 and S3: I am a bit confused about how the obviously decreased NFkappaB nuclear signal (e.g., in Figure 3D) does not translate into a skewed N/C ratio (e.g., in Figure 3C)? The western blots indicate that overall NFkappaB levels remain essentially unchanged? Am I missing something?</p></disp-quote><p>As stated in the Methods section, we used a 50-pixel expansion of the detected nuclear area as our cytoplasmic area in the analysis (see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). This was because we found detecting and segmenting the whole cytoplasmic area in the NF-κB channel to be unreliable. At day 3 and 5, the decrease in NF-κB nuclear signal in RAS cells on TPR knockdown was accompanied by a decrease in signal in the portion of the cytoplasm closest to the nucleus. This led to no change in the nuclear:cytoplasmic ratio. We believe the redistribution of NF-κB closer to the nucleus in the RAS siCTRL sample indicates early activation and will make this clearer in the revised text. We have also quantified the NF-κB immunoblots (see point 5), to help clarification of this issue<bold>.</bold></p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-sa2-fig1-v3.tif"/></fig><disp-quote content-type="editor-comment"><p>5. Also, along these lines, d8 western blots seem to portray an overall drop in NFkappaB levels. Is this indeed so? Can the authors maybe quantify their blots' replicates and provide a box plot and statistical testing?</p></disp-quote><p>We now provide quantification for the NF-κB western blots, indicated below the blots in Figures 2, 3 and 4, and the corresponding supplementary figures, with NF-κB/loading control ratios in RASsiCTRL samples normalised to 1.0. Box plots would not be appropriate as we only have two replicates per experiment<bold>.</bold></p><disp-quote content-type="editor-comment"><p>6. Regarding the ATAC-seq data from d3, I think it could be mined a bit more. For example, compare to d8 (which the authors have apparently done, but don't present in detail) and discuss which are these early regions that also become accessible by d3 and what kind of genes and motifs are associated with them. Moreover, the focus in Figure S3E is on ATAC sites shared with d8; how about d3-specific ones? How many of these are there (if any) and how might they be affected?</p></disp-quote><p>As shown previously in Table S2, now Table 3 in the revised manuscript, TPR knockdown did not cause any changes in chromatin accessibility at day 3, so there are no day 3 specific TPR dependent peaks. We have made this clearer in the revised text (pg 7). At the reviewer’s suggestion, we have now included motif analysis and GREAT analysis on the day 3 peaks that become accessible in RAS cells but that are not accessible in STOP (RAS-specific peaks). This is shown in a new Figure 3 – figure supplement 2.</p><disp-quote content-type="editor-comment"><p>7. I trust that the authors quantified their STING blots for the conclusions they present, but since it is difficult to assess these confidently by eye, again, some quantification plots would be welcome in Figures4C,D and S4D,E.</p></disp-quote><p>Quantification for the STING western blots is now included in Figure 4 and the corresponding supplementary figure.</p><disp-quote content-type="editor-comment"><p>8. As controls for Figure 5, it would be interesting to see if active histone readouts also mark CCFs in this system.</p></disp-quote><p>Ivanov et al., J. Cell Biol., 2013 showed the absence of H3K9 acetylation from chromatin in CCFs. Further exploration of the types of chromatin/sequences in CCFs is outside the scope of our current manuscript.</p><disp-quote content-type="editor-comment"><p>9. The POM121 channel in Figure 5C appears to have some small signal foci in the cytoplasm; could these be small CCFs? More generally, the authors focus on these large blobs that only appear in &lt;6% of cells in d3 and d5. Does this increase by d8? What is the effect of TPR knockdown on CCF numbers at that later time point?</p></disp-quote><p>The small foci the reviewer is highlighting are background from the POM121 antibody staining rather than CCFs – they do not stain with DAPI, and similar foci are evident in non-senescent cells where CCFs are generally not present. Our unpublished data (see response to Reviewer 1, point iv) from day 8 cells shows that only ~2% of senescent cells are CCF positive regardless of TPR knockdown, which is a similar number to that observed in non-senescent cells at earlier timepoints. Thus, in our hands CCF formation occurs earlier, triggering the SASP, rather than at day 8 when the SASP is already established and reinforced through positive feedback cytokine signalling.</p><disp-quote content-type="editor-comment"><p>10. I wonder if there is a simple experiment the authors could do to test if this mechanism is only linked to senescence, specifically oncogene-induced senescence? I don't think this is needed to support the conclusions drawn here, but it could significantly broaden the scope of their discovery of, for example, this was true in other senescence models or during proinflammatory activation in general?</p></disp-quote><p>These are interesting suggestions, but setting up other senescence models is outside the scope of our current manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3</p><p>1. The study uses a single cell strain IMR90 undergoing a single form of senescence, induced by activated Ras. To show the generalizability of the finding, the authors are advised to inhibit TPR in other forms of senescence in addition to IMR90. For example, IR or etoposide induces greater amount of CCF than in OIS of IMR90. BJ, MEFs, and ARPE-19 senescence also show prominent CCF.</p></disp-quote><p>These are interesting suggestions, but setting up other senescence models is outside the scope of our current manuscript.</p><disp-quote content-type="editor-comment"><p>2. To convincing show the CCF pathway is involved, the authors need to measure the activity of cGAS-STING pathway. Including cGAMP ELISA will be informative.</p></disp-quote><p>We thank the reviewer for this suggestion, and we will try to include this assay in our revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. The authors used conditioned media to show that TPR KD does not directly affect NFkB nuclear translocation. While this is helpful, conditions other than senescence will be more direct. For example, TNFa treatment or poly I:C transfection induces efficient NFkB nuclear translocation in IMR90 cells.</p></disp-quote><p>This experiment (Figure 2EF) was designed to simply show that knocking down TPR does not impair the ability of activated NFkB to enter the nucleus, it is not about senescence per se. Indeed, this is why we included the addition of SASP (RAS) conditioned media to non-senescence STOP cells in Figure 2. We do not think investigating other methods of activating NFkB would add more to the question of whether TPR loss abrogates NFkB nuclear import.</p><disp-quote content-type="editor-comment"><p>4. Figure 4C and Figure S4D are identical.</p></disp-quote><p>Though these STING immunoblots look similar; in fact they are not identical. Below we attach the raw original image in which both biological replicates (Figure 4C and S4D) for Day 3 were run on the same gel as proof of this claim.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-101702-sa2-fig2-v3.tif"/></fig><disp-quote content-type="editor-comment"><p>5. Figure legend for Figure S4F is mislabeled.</p></disp-quote><p>We will correct this.</p><p><italic>Description of the revisions that have already been incorporated in the transferred manuscript</italic></p><p>In response to the reviewer 1’s comment, we now refer to ATAC-seq peaks only as “putative enhancers”.</p><p>In response to reviewer 2’s suggestion, in the Introduction we now refer to the literature showing that TPR is the final component added to the nuclear pore and that its absence does not affect localisation of NUP153 to the nuclear basket (Hase and Cordes., Mol. Biol. Cell 2003; Aksenova et al., Nat Comms, 2020).</p><p>As suggested by Reviewer 2 we have included magnified images of representative cells per in a revised version of Figure 2E.</p><p>The Figure legend for Figure S4F has been corrected.</p><p><italic>Description of analyses that authors prefer not to carry out</italic></p><p>Reviewer 2 suggested that as further controls for Figure 5, it might be interesting to see if active histone readouts also mark CCFs in this system. However, Ivanov et al., J. Cell Biol., 2013 already showed the absence of H3K9 acetylation from chromatin in CCFs. Further exploration of the types of chromatin/sequences in CCFs is outside the scope of our current manuscript.</p><p>Reviewers 2 and 3 suggested that it might be interesting – though not essential -to broaden the scope of our discovery of the link between TPR and CCF formation to other senescence models or during proinflammatory activation in general. Setting up other senescence models is outside the scope of our current manuscript and beyond our resources, as the lead author of this manuscript has now finished her PhD and is moving on and a major grant supporting this work has now finished.</p><p>Reviewer 3 suggested examining NFkB nuclear translocation after TPR knockdown using other methods of NFkB activation apart from conditioned media from senescent cells. However, the experiment referred to (Figure 2EF) was only designed to show that knocking down TPR does not impair the ability of activated NFkB to enter the nucleus, it is not about senescence per se. We do not think investigating other methods of activating NFkB would add more to the question of whether TPR loss abrogates NFkB nuclear import<italic>.</italic></p><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>Based on the previous reviews and the revisions, the manuscript has been improved sufficiently for two out of three reviewers. There are some remaining issues that need to be addressed before we can proceed to publication -- one reviewer noted major files were missing in the merged version they reviewed, they ask you to ensure the files are present. The third reviewer is still unconvinced on some key points – I suggest including a rebuttal that specifically addresses those points, and textual clarification that will assist readers of this work.</p><p>Reviewer #1:</p><p>The authors have addressed all of my questions and have conducted additional experiments. However, the manuscript is not yet ready for acceptance. I was unable to locate the tables and supplementary files mentioned, which may have been omitted by mistake. Please ensure these are uploaded. I expect that Table 2, as per my recommendation, is included as claimed in the text. If so, after editorial screening, the manuscript can be accepted. The authors have made significant strides in advancing our understanding of the SAHF-CCF-SASP axis. Their innovative approach, combined with thorough experimental work, provides compelling evidence linking heterochromatin reorganization to CCF formation.</p><p>Reviewer #3:</p><p>In the revised manuscript, the authors claimed that TPR is required for CCF formation during senescence. However, this conclusion is unsupported by the new data. In fact, the results collectively suggest an alternative pathway of how TPR regulates the SASP. As articulated below, there are serious major issues that preclude publication of this manuscript at eLife.</p><p>1. The study uses a single cell strain IMR90 undergoing a single form of senescence, induced by activated Ras. CCF in this system is less than 6%, arguing against a central role for CCF in mediating the NFkB pathway. Additional systems with more robust CCF must be included.</p></disp-quote><p>We appreciate the reviewer’s feedback regarding the use of a single cell strain (IMR90) undergoing oncogene-induced senescence (OIS) via Ras activation. The IMR90 cell line, induced by the ER:RAS system, is a well-established and widely used model to study CCF (cytoplasmic chromatin fragment) formation. It has been validated in previous studies, including Ivanov et al. (Journal of Cell Biology 2013), Dou et al. (Nature 2017), Vizioli et al. (Genes Dev. 2020), Liu et al. (Nature Cell Biology 2021), Zhao et al. (Nature Communications 2020) and Hao et al. (Nature Aging 2024).</p><p>In our study, we measured CCFs at early time points (3 &amp; 5 days post Ras induction), which corresponds to the period when we observed effects on NF-κB activation. At this stage, CCFs were detected in less than 10% of cells, consistent with prior findings by Dou et al. Importantly, we chose to investigate these early time points because they coincided with when we observed significant TPR-related effects on NF-κB signaling.</p><p>Although the observed CCF frequency (~6%) may seem modest, we argue that this is sufficient to drive NF-κB activation. We propose that paracrine and juxtracrine signaling mechanisms, such as IL1B-mediated effects, could explain how a small fraction of cells influences NF-κB activation and the broader SASP (senescence-associated secretory phenotype) response in the entire cell population. In fact, our experiments on paracrine SASP activation demonstrate that TPR-depleted cells remain responsive to paracrine SASP signaling, leading to NF-κB activation (Figure 2E,F and Figure 2—figure supplement 1D). This further supports the notion that even a seemingly small population of CCF-positive cells can exert a significant influence via paracrine pathways.</p><p>Additionally, we acknowledge that our measurements represent a fixed snapshot of the CCF state, without accounting for the dynamic nature of the process, including CCF turnover and degradation. It is plausible that CCFs are part of a highly dynamic process, which could result in underestimation of the actual CCF presence at a given time.</p><disp-quote content-type="editor-comment"><p>2. The authors presented new data showing that cGAMP is induced in OIS. However, disruption of TPR had no effect on cGAMP level. This result suggests that cGAS is not affected by TPR, again arguing against the central conclusion that CCF is involved.</p></disp-quote><p>It is not quite correct to say that TPR has no effect on cGAMP levels. While Ras activation leads to a significant increase in cGAMP levels compared to the control STOP cells in siCTRL sample (Figure 4D and Figure 4 source data 1), this does not occur when TPR is knocked down in RAS vs STOP cells. The reviewer is correct that the decreased cGAMP levels in RAS cells after TPR knockdown, compared with RAS siCTRL, is not statistically significant, and we have clearly stated this in the text.</p><disp-quote content-type="editor-comment"><p>3. The results that TPR affects STING expression level suggest that TPR does not go through CCF to regulate NFkB. First, CCF is not known to regulate STING expression level. Second, TPR may affect mRNA processing to regulate STING expression, which again can be independent of CCF. This alternative interpretation makes more sense to this reviewer, as I do not see how CCF is a central player regulated by TPR.</p></disp-quote><p>We agree with the reviewer on this point. But in our model, TPR contributes to NF-κB regulation not only through its effect on CCF formation but also by influencing STING expression. Together, these effects combine to regulate TBK1 activity and subsequently NF-κB activation and the SASP. To clarify this, we have added a revised model in Figure 5 to better illustrate these interconnected pathways. Further research will be necessary to disentangle the specific contributions of each component of TPR’s effect on SASP regulation and to better understand the dynamics of these processes.</p><disp-quote content-type="editor-comment"><p>4. The authors suggest that the formation of SAHF is linked to CCF. However, BJ cells undergoing IR and replicative senescence show prominent CCF without SAHF. Again, without testing the generalizability of the finding, the authors overinterpreted the results using a single system.</p></disp-quote><p>We agree with the reviewer that we may have over-generalised the link between SAHF formation and CCF generation, as many cells such as BJs can indeed form CCFs without developing SAHFs. We have now clarified this at the end of the Discussion. “Whether TPR has a similar role in other models of OIS, or for other triggers of senescence and in aging where SAHFs may not be present, remains to be determined”.</p><disp-quote content-type="editor-comment"><p>All in all, the central conclusion of CCF is unsupported by the data. However, I do believe the NFkB and STING data. I suggest that the authors remove CCF data and focus on how TPR regulates STING expression. To establish TPR goes through STING to affect NFkB, I suggest overexpressing STING in TPR knockdown senescent cells, and check if NFkB and SASP can be restored.</p></disp-quote></body></sub-article></article>